"""KEGG Pathway ID""","""P value""","""Contrast""","""-log10Pvalue""","""Pathway Name""","""BH-adjusted p vals""","""-log10(adjusted p-vals"""
hsa05225,2.39E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.622228187,Hepatocellular carcinoma,0.016514975,1.782122092
hsa04962,0.485402892,"1% O2, CyA+ vs 1% O2, CyA-",0.31389764,Vasopressin-regulated water reabsorption,1,0
hsa03250,4.40E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.356700373,Viral life cycle - HIV-1,0.000322846,3.491004314
hsa04912,0.000210039,"1% O2, CyA+ vs 1% O2, CyA-",3.677699401,GnRH signaling pathway,0.139466107,0.855531322
hsa05218,0.007950786,"1% O2, CyA+ vs 1% O2, CyA-",2.099589913,Melanoma,1,0
hsa00100,5.29E-29,"1% O2, CyA+ vs 1% O2, CyA-",28.27660797,Steroid biosynthesis,4.47E-26,25.34975126
hsa00830,0.473338278,"1% O2, CyA+ vs 1% O2, CyA-",0.324828373,Retinol metabolism,1,0
hsa00785,0.546738171,"1% O2, CyA+ vs 1% O2, CyA-",0.262220604,Lipoic acid metabolism,1,0
hsa04625,1.05E-16,"1% O2, CyA+ vs 1% O2, CyA-",15.97829426,C-type lectin receptor signaling pathway,8.50E-14,13.07034574
hsa05221,0.006905841,"1% O2, CyA+ vs 1% O2, CyA-",2.160783403,Acute myeloid leukemia,1,0
hsa04145,0.005125322,"1% O2, CyA+ vs 1% O2, CyA-",2.290278875,Phagosome,1,0
hsa05217,0.24924421,"1% O2, CyA+ vs 1% O2, CyA-",0.603374922,Basal cell carcinoma,1,0
hsa05223,0.098618977,"1% O2, CyA+ vs 1% O2, CyA-",1.006039507,Non-small cell lung cancer,1,0
hsa05330,0.542973899,"1% O2, CyA+ vs 1% O2, CyA-",0.265221046,Allograft rejection,1,0
hsa04022,0.010458158,"1% O2, CyA+ vs 1% O2, CyA-",1.980544817,cGMP-PKG signaling pathway,1,0
hsa00140,0.502254092,"1% O2, CyA+ vs 1% O2, CyA-",0.299076516,Steroid hormone biosynthesis,1,0
hsa04066,2.08E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.681934179,HIF-1 signaling pathway,0.000154337,3.811530273
hsa04724,0.440638395,"1% O2, CyA+ vs 1% O2, CyA-",0.355917663,Glutamatergic synapse,1,0
hsa05012,0.306961082,"1% O2, CyA+ vs 1% O2, CyA-",0.512916684,Parkinson disease,1,0
hsa05146,0.439039797,"1% O2, CyA+ vs 1% O2, CyA-",0.357496111,Amoebiasis,1,0
hsa05410,0.38944401,"1% O2, CyA+ vs 1% O2, CyA-",0.409554971,Hypertrophic cardiomyopathy,1,0
hsa00510,0.471088198,"1% O2, CyA+ vs 1% O2, CyA-",0.326897776,N-Glycan biosynthesis,1,0
hsa04114,1.13E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.945644753,Oocyte meiosis,0.007944622,2.099926735
hsa04310,0.009041093,"1% O2, CyA+ vs 1% O2, CyA-",2.043779081,Wnt signaling pathway,1,0
hsa03015,5.99E-19,"1% O2, CyA+ vs 1% O2, CyA-",18.22252008,mRNA surveillance pathway,4.90E-16,15.30976678
hsa03440,0.150469739,"1% O2, CyA+ vs 1% O2, CyA-",0.822550831,Homologous recombination,1,0
hsa05152,0.126959692,"1% O2, CyA+ vs 1% O2, CyA-",0.89633414,Tuberculosis,1,0
hsa04110,0.077525807,"1% O2, CyA+ vs 1% O2, CyA-",1.110553706,Cell cycle,1,0
hsa00604,0.524190367,"1% O2, CyA+ vs 1% O2, CyA-",0.280510965,Glycosphingolipid biosynthesis - ganglio series,1,0
hsa05416,0.014238786,"1% O2, CyA+ vs 1% O2, CyA-",1.846527029,Viral myocarditis,1,0
hsa04664,1.78E-26,"1% O2, CyA+ vs 1% O2, CyA-",25.74964001,Fc epsilon RI signaling pathway,1.49E-23,22.82743374
hsa04929,3.69E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.433405133,GnRH secretion,0.025214535,1.598349031
hsa04136,2.42E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.616556858,Autophagy - other,0.016707874,1.777078811
hsa04660,3.18E-10,"1% O2, CyA+ vs 1% O2, CyA-",9.497314504,T cell receptor signaling pathway,2.46E-07,6.60913501
hsa00310,0.002588877,"1% O2, CyA+ vs 1% O2, CyA-",2.586888577,Lysine degradation,1,0
hsa04070,0.334544561,"1% O2, CyA+ vs 1% O2, CyA-",0.475546026,Phosphatidylinositol signaling system,1,0
hsa04726,0.004308806,"1% O2, CyA+ vs 1% O2, CyA-",2.365643022,Serotonergic synapse,1,0
hsa05332,0.538107978,"1% O2, CyA+ vs 1% O2, CyA-",0.269130569,Graft-versus-host disease,1,0
hsa04916,0.002032073,"1% O2, CyA+ vs 1% O2, CyA-",2.692060621,Melanogenesis,1,0
hsa05169,0.159107193,"1% O2, CyA+ vs 1% O2, CyA-",0.798310187,Epstein-Barr virus infection,1,0
hsa00900,0.021967836,"1% O2, CyA+ vs 1% O2, CyA-",1.65821272,Terpenoid backbone biosynthesis,1,0
hsa00591,0.517449046,"1% O2, CyA+ vs 1% O2, CyA-",0.286132409,Linoleic acid metabolism,1,0
hsa04024,0.028281292,"1% O2, CyA+ vs 1% O2, CyA-",1.548500754,cAMP signaling pathway,1,0
hsa04068,1.47E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.831493261,FoxO signaling pathway,0.001064251,2.972956063
hsa00520,0.304449598,"1% O2, CyA+ vs 1% O2, CyA-",0.516484595,Amino sugar and nucleotide sugar metabolism,1,0
hsa00860,0.469639488,"1% O2, CyA+ vs 1% O2, CyA-",0.328235394,Porphyrin metabolism,1,0
hsa04922,8.24E-09,"1% O2, CyA+ vs 1% O2, CyA-",8.083907824,Glucagon signaling pathway,6.28E-06,5.201952853
hsa04926,0.040886764,"1% O2, CyA+ vs 1% O2, CyA-",1.388417262,Relaxin signaling pathway,1,0
hsa04370,5.56E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.25513009,VEGF signaling pathway,0.037790168,1.422621177
hsa05213,2.16E-20,"1% O2, CyA+ vs 1% O2, CyA-",19.66584672,Endometrial cancer,1.79E-17,16.74834121
hsa04520,2.05E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.688542152,Adherens junction,0.01419682,1.847808917
hsa05110,0.005573047,"1% O2, CyA+ vs 1% O2, CyA-",2.253907281,Vibrio cholerae infection,1,0
hsa05220,0.01107227,"1% O2, CyA+ vs 1% O2, CyA-",1.955763341,Chronic myeloid leukemia,1,0
hsa05235,2.28E-09,"1% O2, CyA+ vs 1% O2, CyA-",8.641407738,PD-L1 expression and PD-1 checkpoint pathway in cancer,1.75E-06,5.757178968
hsa05207,0.000317809,"1% O2, CyA+ vs 1% O2, CyA-",3.497833288,Chemical carcinogenesis - receptor activation,0.209118572,0.679607395
hsa05418,0.185697094,"1% O2, CyA+ vs 1% O2, CyA-",0.731194891,Fluid shear stress and atherosclerosis,1,0
hsa00920,0.526078127,"1% O2, CyA+ vs 1% O2, CyA-",0.278949755,Sulfur metabolism,1,0
hsa04931,0.000107576,"1% O2, CyA+ vs 1% O2, CyA-",3.96828662,Insulin resistance,0.072398313,1.140271556
hsa00500,0.029594369,"1% O2, CyA+ vs 1% O2, CyA-",1.528790911,Starch and sucrose metabolism,1,0
hsa05216,0.413889761,"1% O2, CyA+ vs 1% O2, CyA-",0.383115317,Thyroid cancer,1,0
hsa00740,0.416577316,"1% O2, CyA+ vs 1% O2, CyA-",0.380304382,Riboflavin metabolism,1,0
hsa00062,0.238148317,"1% O2, CyA+ vs 1% O2, CyA-",0.623152484,Fatty acid elongation,1,0
hsa04390,0.017639581,"1% O2, CyA+ vs 1% O2, CyA-",1.753511741,Hippo signaling pathway,1,0
hsa04064,0.200499339,"1% O2, CyA+ vs 1% O2, CyA-",0.697887056,NF-kappa B signaling pathway,1,0
hsa04932,0.261589783,"1% O2, CyA+ vs 1% O2, CyA-",0.582379222,Non-alcoholic fatty liver disease,1,0
hsa05222,0.040715159,"1% O2, CyA+ vs 1% O2, CyA-",1.390243869,Small cell lung cancer,1,0
hsa05320,0.555825981,"1% O2, CyA+ vs 1% O2, CyA-",0.255061157,Autoimmune thyroid disease,1,0
hsa04115,0.047903579,"1% O2, CyA+ vs 1% O2, CyA-",1.319632042,p53 signaling pathway,1,0
hsa04710,0.16026983,"1% O2, CyA+ vs 1% O2, CyA-",0.795148223,Circadian rhythm,1,0
hsa05206,0.000664617,"1% O2, CyA+ vs 1% O2, CyA-",3.177428361,MicroRNAs in cancer,0.430672008,0.365853355
hsa05032,0.471311617,"1% O2, CyA+ vs 1% O2, CyA-",0.326691856,Morphine addiction,1,0
hsa00620,0.333223843,"1% O2, CyA+ vs 1% O2, CyA-",0.477263931,Pyruvate metabolism,1,0
hsa05132,0.197136268,"1% O2, CyA+ vs 1% O2, CyA-",0.705233469,Salmonella infection,1,0
hsa04658,0.141718556,"1% O2, CyA+ vs 1% O2, CyA-",0.848573281,Th1 and Th2 cell differentiation,1,0
hsa05014,0.035159077,"1% O2, CyA+ vs 1% O2, CyA-",1.453962531,Amyotrophic lateral sclerosis,1,0
hsa04933,0.476379252,"1% O2, CyA+ vs 1% O2, CyA-",0.322047162,AGE-RAGE signaling pathway in diabetic complications,1,0
hsa00531,0.485347525,"1% O2, CyA+ vs 1% O2, CyA-",0.313947181,Glycosaminoglycan degradation,1,0
hsa04714,0.068379879,"1% O2, CyA+ vs 1% O2, CyA-",1.165071672,Thermogenesis,1,0
hsa00592,0.466665162,"1% O2, CyA+ vs 1% O2, CyA-",0.330994619,alpha-Linolenic acid metabolism,1,0
hsa05170,8.34E-08,"1% O2, CyA+ vs 1% O2, CyA-",7.079090196,Human immunodeficiency virus 1 infection,6.23E-05,4.205188598
hsa05160,3.13E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.504919753,Hepatitis C,0.021448867,1.668595637
hsa04392,0.058209274,"1% O2, CyA+ vs 1% O2, CyA-",1.23500782,Hippo signaling pathway - multiple species,1,0
hsa04666,0.000594621,"1% O2, CyA+ vs 1% O2, CyA-",3.225760097,Fc gamma R-mediated phagocytosis,0.386503348,0.41284674
hsa04920,0.062307327,"1% O2, CyA+ vs 1% O2, CyA-",1.20546088,Adipocytokine signaling pathway,1,0
hsa04940,0.551177269,"1% O2, CyA+ vs 1% O2, CyA-",0.258708702,Type I diabetes mellitus,1,0
hsa04672,0.076492279,"1% O2, CyA+ vs 1% O2, CyA-",1.1163824,Intestinal immune network for IgA production,1,0
hsa00780,0.52330708,"1% O2, CyA+ vs 1% O2, CyA-",0.281243389,Biotin metabolism,1,0
hsa00590,0.311927056,"1% O2, CyA+ vs 1% O2, CyA-",0.505946954,Arachidonic acid metabolism,1,0
hsa05161,0.019990237,"1% O2, CyA+ vs 1% O2, CyA-",1.699182053,Hepatitis B,1,0
hsa04540,1.97E-42,"1% O2, CyA+ vs 1% O2, CyA-",41.70490138,Gap junction,1.70E-39,38.77040293
hsa04913,0.158010599,"1% O2, CyA+ vs 1% O2, CyA-",0.801313781,Ovarian steroidogenesis,1,0
hsa05212,0.265537518,"1% O2, CyA+ vs 1% O2, CyA-",0.575874108,Pancreatic cancer,1,0
hsa05211,2.63E-271,"1% O2, CyA+ vs 1% O2, CyA-",270.5798304,Renal cell carcinoma,2.32E-268,267.6353478
hsa04371,0.000998833,"1% O2, CyA+ vs 1% O2, CyA-",3.000507143,Apelin signaling pathway,0.639253082,0.19432717
hsa05164,0.057380646,"1% O2, CyA+ vs 1% O2, CyA-",1.241234567,Influenza A,1,0
hsa04146,0.068765905,"1% O2, CyA+ vs 1% O2, CyA-",1.162626839,Peroxisome,1,0
hsa04122,3.89E-19,"1% O2, CyA+ vs 1% O2, CyA-",18.41040384,Sulfur relay system,3.18E-16,15.49711994
hsa05167,0.282896777,"1% O2, CyA+ vs 1% O2, CyA-",0.548372,Kaposi sarcoma-associated herpesvirus infection,1,0
hsa00562,0.429212441,"1% O2, CyA+ vs 1% O2, CyA-",0.367327698,Inositol phosphate metabolism,1,0
hsa04935,0.000493747,"1% O2, CyA+ vs 1% O2, CyA-",3.306495219,"Growth hormone synthesis, secretion and action",0.321429527,0.49291423
hsa00240,0.290162604,"1% O2, CyA+ vs 1% O2, CyA-",0.53735856,Pyrimidine metabolism,1,0
hsa05200,0.241681287,"1% O2, CyA+ vs 1% O2, CyA-",0.616756975,Pathways in cancer,1,0
hsa00480,0.382340202,"1% O2, CyA+ vs 1% O2, CyA-",0.417550035,Glutathione metabolism,1,0
hsa04150,8.15E-08,"1% O2, CyA+ vs 1% O2, CyA-",7.089073419,mTOR signaling pathway,6.10E-05,4.214591602
hsa05034,5.03E-09,"1% O2, CyA+ vs 1% O2, CyA-",8.298568104,Alcoholism,3.85E-06,5.414906668
hsa04750,0.17651176,"1% O2, CyA+ vs 1% O2, CyA-",0.753226354,Inflammatory mediator regulation of TRP channels,1,0
hsa04137,0.074295808,"1% O2, CyA+ vs 1% O2, CyA-",1.129035689,Mitophagy - animal,1,0
hsa05203,0.000358105,"1% O2, CyA+ vs 1% O2, CyA-",3.445990035,Viral carcinogenesis,0.234916653,0.629086195
hsa03320,0.466045628,"1% O2, CyA+ vs 1% O2, CyA-",0.331571562,PPAR signaling pathway,1,0
hsa00564,0.483206326,"1% O2, CyA+ vs 1% O2, CyA-",0.315867389,Glycerophospholipid metabolism,1,0
hsa04961,0.467246789,"1% O2, CyA+ vs 1% O2, CyA-",0.330453674,Endocrine and other factor-regulated calcium reabsorption,1,0
hsa00220,0.505906783,"1% O2, CyA+ vs 1% O2, CyA-",0.295929498,Arginine biosynthesis,1,0
hsa05168,5.49E-30,"1% O2, CyA+ vs 1% O2, CyA-",29.26033348,Herpes simplex virus 1 infection,4.65E-27,26.33296311
hsa04061,0.002839532,"1% O2, CyA+ vs 1% O2, CyA-",2.546753262,Viral protein interaction with cytokine and cytokine receptor,1,0
hsa05412,0.362722894,"1% O2, CyA+ vs 1% O2, CyA-",0.440425032,Arrhythmogenic right ventricular cardiomyopathy,1,0
hsa04924,0.004161212,"1% O2, CyA+ vs 1% O2, CyA-",2.380780176,Renin secretion,1,0
hsa05143,0.468686435,"1% O2, CyA+ vs 1% O2, CyA-",0.329117616,African trypanosomiasis,1,0
hsa04960,0.027248614,"1% O2, CyA+ vs 1% O2, CyA-",1.564655589,Aldosterone-regulated sodium reabsorption,1,0
hsa05162,0.361770462,"1% O2, CyA+ vs 1% O2, CyA-",0.441566896,Measles,1,0
hsa00730,0.43304618,"1% O2, CyA+ vs 1% O2, CyA-",0.363465788,Thiamine metabolism,1,0
hsa05030,0.251852605,"1% O2, CyA+ vs 1% O2, CyA-",0.598853552,Cocaine addiction,1,0
hsa00750,0.389043903,"1% O2, CyA+ vs 1% O2, CyA-",0.410001386,Vitamin B6 metabolism,1,0
hsa04623,0.223158959,"1% O2, CyA+ vs 1% O2, CyA-",0.651385672,Cytosolic DNA-sensing pathway,1,0
hsa00650,0.392968234,"1% O2, CyA+ vs 1% O2, CyA-",0.405642554,Butanoate metabolism,1,0
hsa05010,0.040749785,"1% O2, CyA+ vs 1% O2, CyA-",1.389874673,Alzheimer disease,1,0
hsa05031,0.189083703,"1% O2, CyA+ vs 1% O2, CyA-",0.7233459,Amphetamine addiction,1,0
hsa00071,0.099178499,"1% O2, CyA+ vs 1% O2, CyA-",1.003582467,Fatty acid degradation,1,0
hsa00561,0.397036021,"1% O2, CyA+ vs 1% O2, CyA-",0.40117009,Glycerolipid metabolism,1,0
hsa04614,0.040810643,"1% O2, CyA+ vs 1% O2, CyA-",1.38922656,Renin-angiotensin system,1,0
hsa04971,0.000176087,"1% O2, CyA+ vs 1% O2, CyA-",3.754272896,Gastric acid secretion,0.117449978,0.930147062
hsa04215,0.043223212,"1% O2, CyA+ vs 1% O2, CyA-",1.364282966,Apoptosis - multiple species,1,0
hsa04080,0.363806356,"1% O2, CyA+ vs 1% O2, CyA-",0.439129718,Neuroactive ligand-receptor interaction,1,0
hsa05231,0.086590006,"1% O2, CyA+ vs 1% O2, CyA-",1.062532232,Choline metabolism in cancer,1,0
hsa05166,5.56E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.255233584,Human T-cell leukemia virus 1 infection,0.003922574,2.406428883
hsa00790,0.178303378,"1% O2, CyA+ vs 1% O2, CyA-",0.748840429,Folate biosynthesis,1,0
hsa00983,0.238045487,"1% O2, CyA+ vs 1% O2, CyA-",0.623340048,Drug metabolism - other enzymes,1,0
hsa04721,0.206193927,"1% O2, CyA+ vs 1% O2, CyA-",0.68572413,Synaptic vesicle cycle,1,0
hsa04218,4.20E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.376713146,Cellular senescence,0.028646478,1.542928771
hsa04530,0.205218766,"1% O2, CyA+ vs 1% O2, CyA-",0.687782927,Tight junction,1,0
hsa04340,0.048904728,"1% O2, CyA+ vs 1% O2, CyA-",1.310649151,Hedgehog signaling pathway,1,0
hsa04725,0.067676252,"1% O2, CyA+ vs 1% O2, CyA-",1.169563704,Cholinergic synapse,1,0
hsa04740,0.540835268,"1% O2, CyA+ vs 1% O2, CyA-",0.266934996,Olfactory transduction,1,0
hsa04152,2.79E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.554196062,AMPK signaling pathway,0.00200135,2.698676906
hsa03460,1.01E-64,"1% O2, CyA+ vs 1% O2, CyA-",63.99766457,Fanconi anemia pathway,8.70E-62,61.06064846
hsa05214,0.000926055,"1% O2, CyA+ vs 1% O2, CyA-",3.033363048,Glioma,0.595453599,0.225152075
hsa00440,0.528350326,"1% O2, CyA+ vs 1% O2, CyA-",0.277078021,Phosphonate and phosphinate metabolism,1,0
hsa04020,0.117095934,"1% O2, CyA+ vs 1% O2, CyA-",0.931458185,Calcium signaling pathway,1,0
hsa04514,0.373171329,"1% O2, CyA+ vs 1% O2, CyA-",0.42809173,Cell adhesion molecules,1,0
hsa04613,0.09810772,"1% O2, CyA+ vs 1% O2, CyA-",1.008296819,Neutrophil extracellular trap formation,1,0
hsa00250,0.44214412,"1% O2, CyA+ vs 1% O2, CyA-",0.354436146,"Alanine, aspartate and glutamate metabolism",1,0
hsa04217,0.118864271,"1% O2, CyA+ vs 1% O2, CyA-",0.92494867,Necroptosis,1,0
hsa04934,1.01E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.994211912,Cushing syndrome,0.000736754,3.132677501
hsa05140,0.059218826,"1% O2, CyA+ vs 1% O2, CyA-",1.227540204,Leishmaniasis,1,0
hsa04919,3.66E-08,"1% O2, CyA+ vs 1% O2, CyA-",7.436117332,Thyroid hormone signaling pathway,2.76E-05,4.558745986
hsa04550,0.239525304,"1% O2, CyA+ vs 1% O2, CyA-",0.6206486,Signaling pathways regulating pluripotency of stem cells,1,0
hsa00061,0.028764591,"1% O2, CyA+ vs 1% O2, CyA-",1.54114179,Fatty acid biosynthesis,1,0
hsa00532,0.432938802,"1% O2, CyA+ vs 1% O2, CyA-",0.363573489,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0
hsa04742,0.300411136,"1% O2, CyA+ vs 1% O2, CyA-",0.522283973,Taste transduction,1,0
hsa04261,0.097654823,"1% O2, CyA+ vs 1% O2, CyA-",1.010306304,Adrenergic signaling in cardiomyocytes,1,0
hsa04910,3.62E-12,"1% O2, CyA+ vs 1% O2, CyA-",11.44166274,Insulin signaling pathway,2.84E-09,8.546240197
hsa04015,0.002322296,"1% O2, CyA+ vs 1% O2, CyA-",2.634082458,Rap1 signaling pathway,1,0
hsa05208,1.64E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.78643614,Chemical carcinogenesis - reactive oxygen species,0.00012182,3.914279868
hsa04914,1.75E-70,"1% O2, CyA+ vs 1% O2, CyA-",69.75617277,Progesterone-mediated oocyte maturation,1.52E-67,66.81865488
hsa04130,0.147477673,"1% O2, CyA+ vs 1% O2, CyA-",0.831273724,SNARE interactions in vesicular transport,1,0
hsa00640,0.133305794,"1% O2, CyA+ vs 1% O2, CyA-",0.875150972,Propanoate metabolism,1,0
hsa00450,0.445042903,"1% O2, CyA+ vs 1% O2, CyA-",0.35159812,Selenocompound metabolism,1,0
hsa04621,0.001837105,"1% O2, CyA+ vs 1% O2, CyA-",2.735866026,NOD-like receptor signaling pathway,1,0
hsa05130,0.056410956,"1% O2, CyA+ vs 1% O2, CyA-",1.24863654,Pathogenic Escherichia coli infection,1,0
hsa04670,0.15699353,"1% O2, CyA+ vs 1% O2, CyA-",0.804118246,Leukocyte transendothelial migration,1,0
hsa04928,0.030027783,"1% O2, CyA+ vs 1% O2, CyA-",1.52247673,"Parathyroid hormone synthesis, secretion and action",1,0
hsa00130,0.427186007,"1% O2, CyA+ vs 1% O2, CyA-",0.369382982,Ubiquinone and other terpenoid-quinone biosynthesis,1,0
hsa05100,0.125045104,"1% O2, CyA+ vs 1% O2, CyA-",0.902933308,Bacterial invasion of epithelial cells,1,0
hsa05414,0.439203169,"1% O2, CyA+ vs 1% O2, CyA-",0.357334535,Dilated cardiomyopathy,1,0
hsa05321,0.447414844,"1% O2, CyA+ vs 1% O2, CyA-",0.349289611,Inflammatory bowel disease,1,0
hsa00051,0.071364241,"1% O2, CyA+ vs 1% O2, CyA-",1.14651935,Fructose and mannose metabolism,1,0
hsa05230,1.14E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.94441333,Central carbon metabolism in cancer,8.49E-05,4.071092728
hsa04727,0.373665442,"1% O2, CyA+ vs 1% O2, CyA-",0.427517066,GABAergic synapse,1,0
hsa04630,0.001946048,"1% O2, CyA+ vs 1% O2, CyA-",2.710846356,JAK-STAT signaling pathway,1,0
hsa00603,0.564102305,"1% O2, CyA+ vs 1% O2, CyA-",0.248642126,Glycosphingolipid biosynthesis - globo and isoglobo series,1,0
hsa00340,0.337862466,"1% O2, CyA+ vs 1% O2, CyA-",0.471260052,Histidine metabolism,1,0
hsa04610,0.479620622,"1% O2, CyA+ vs 1% O2, CyA-",0.319102152,Complement and coagulation cascades,1,0
hsa05205,0.019818129,"1% O2, CyA+ vs 1% O2, CyA-",1.702937359,Proteoglycans in cancer,1,0
hsa04140,1.19E-26,"1% O2, CyA+ vs 1% O2, CyA-",25.92386198,Autophagy - animal,9.97E-24,23.00113652
hsa00010,0.391500144,"1% O2, CyA+ vs 1% O2, CyA-",0.407268074,Glycolysis / Gluconeogenesis,1,0
hsa04144,2.62E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.581460144,Endocytosis,0.000193724,3.712815705
hsa01521,0.004359801,"1% O2, CyA+ vs 1% O2, CyA-",2.360533337,EGFR tyrosine kinase inhibitor resistance,1,0
hsa05415,0.054289541,"1% O2, CyA+ vs 1% O2, CyA-",1.265283834,Diabetic cardiomyopathy,1,0
hsa05133,2.13E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.671156526,Pertussis,0.000158002,3.801338318
hsa04620,0.091111439,"1% O2, CyA+ vs 1% O2, CyA-",1.040427093,Toll-like receptor signaling pathway,1,0
hsa00980,0.375988375,"1% O2, CyA+ vs 1% O2, CyA-",0.424825583,Metabolism of xenobiotics by cytochrome P450,1,0
hsa01524,9.46E-09,"1% O2, CyA+ vs 1% O2, CyA-",8.024064268,Platinum drug resistance,7.20E-06,5.142679612
hsa00630,0.369610742,"1% O2, CyA+ vs 1% O2, CyA-",0.432255416,Glyoxylate and dicarboxylate metabolism,1,0
hsa05022,0.046867498,"1% O2, CyA+ vs 1% O2, CyA-",1.329128228,Pathways of neurodegeneration - multiple diseases,1,0
hsa05165,0.108500075,"1% O2, CyA+ vs 1% O2, CyA-",0.964569964,Human papillomavirus infection,1,0
hsa04330,1.93E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.715458013,Notch signaling pathway,0.001388281,2.857522748
hsa04927,0.006851663,"1% O2, CyA+ vs 1% O2, CyA-",2.164204001,Cortisol synthesis and secretion,1,0
hsa01523,1.78E-09,"1% O2, CyA+ vs 1% O2, CyA-",8.748469611,Antifolate resistance,1.37E-06,5.863674247
hsa05323,0.479753548,"1% O2, CyA+ vs 1% O2, CyA-",0.318981805,Rheumatoid arthritis,1,0
hsa00563,0.52056241,"1% O2, CyA+ vs 1% O2, CyA-",0.283527196,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1,0
hsa04917,1.47E-15,"1% O2, CyA+ vs 1% O2, CyA-",14.83153213,Prolactin signaling pathway,1.18E-12,11.92789962
hsa05135,5.23E-08,"1% O2, CyA+ vs 1% O2, CyA-",7.281543143,Yersinia infection,3.93E-05,4.405325302
hsa04612,0.001213392,"1% O2, CyA+ vs 1% O2, CyA-",2.915998818,Antigen processing and presentation,0.771717408,0.112541703
hsa00330,0.493889873,"1% O2, CyA+ vs 1% O2, CyA-",0.306369879,Arginine and proline metabolism,1,0
hsa05016,0.033649244,"1% O2, CyA+ vs 1% O2, CyA-",1.473024685,Huntington disease,1,0
hsa04141,2.52E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.598548521,Protein processing in endoplasmic reticulum,0.000186502,3.729316801
hsa04979,0.27424868,"1% O2, CyA+ vs 1% O2, CyA-",0.561855454,Cholesterol metabolism,1,0
hsa00670,0.359094167,"1% O2, CyA+ vs 1% O2, CyA-",0.444791649,One carbon pool by folate,1,0
hsa00260,0.442578177,"1% O2, CyA+ vs 1% O2, CyA-",0.354010004,"Glycine, serine and threonine metabolism",1,0
hsa04730,5.61E-31,"1% O2, CyA+ vs 1% O2, CyA-",30.2509833,Long-term depression,4.76E-28,27.32207561
hsa04650,0.039328114,"1% O2, CyA+ vs 1% O2, CyA-",1.405296876,Natural killer cell mediated cytotoxicity,1,0
hsa04720,1.52E-39,"1% O2, CyA+ vs 1% O2, CyA-",38.8188889,Long-term potentiation,1.30E-36,35.88692279
hsa00360,0.53476907,"1% O2, CyA+ vs 1% O2, CyA-",0.27183372,Phenylalanine metabolism,1,0
hsa05020,4.02E-16,"1% O2, CyA+ vs 1% O2, CyA-",15.39584202,Prion disease,3.23E-13,12.49058598
hsa00760,0.357130928,"1% O2, CyA+ vs 1% O2, CyA-",0.447172538,Nicotinate and nicotinamide metabolism,1,0
hsa05210,0.010079503,"1% O2, CyA+ vs 1% O2, CyA-",1.996560873,Colorectal cancer,1,0
hsa03018,0.055994024,"1% O2, CyA+ vs 1% O2, CyA-",1.25185832,RNA degradation,1,0
hsa00410,0.37283958,"1% O2, CyA+ vs 1% O2, CyA-",0.42847799,beta-Alanine metabolism,1,0
hsa00565,0.435646223,"1% O2, CyA+ vs 1% O2, CyA-",0.360866047,Ether lipid metabolism,1,0
hsa04350,0.218004505,"1% O2, CyA+ vs 1% O2, CyA-",0.661534531,TGF-beta signaling pathway,1,0
hsa05150,0.16428925,"1% O2, CyA+ vs 1% O2, CyA-",0.784390853,Staphylococcus aureus infection,1,0
hsa00120,0.533955664,"1% O2, CyA+ vs 1% O2, CyA-",0.272494802,Primary bile acid biosynthesis,1,0
hsa04810,0.000140982,"1% O2, CyA+ vs 1% O2, CyA-",3.850836746,Regulation of actin cytoskeleton,0.094316868,1.025410628
hsa05144,0.464881481,"1% O2, CyA+ vs 1% O2, CyA-",0.332657754,Malaria,1,0
hsa04072,0.062146105,"1% O2, CyA+ vs 1% O2, CyA-",1.206586087,Phospholipase D signaling pathway,1,0
hsa00910,1.90E-41,"1% O2, CyA+ vs 1% O2, CyA-",40.7212858,Nitrogen metabolism,1.63E-38,37.78729264
hsa00513,0.082499545,"1% O2, CyA+ vs 1% O2, CyA-",1.083548445,Various types of N-glycan biosynthesis,1,0
hsa05134,0.038255209,"1% O2, CyA+ vs 1% O2, CyA-",1.417309419,Legionellosis,1,0
hsa04970,0.255736533,"1% O2, CyA+ vs 1% O2, CyA-",0.592207226,Salivary secretion,1,0
hsa05171,0.115714824,"1% O2, CyA+ vs 1% O2, CyA-",0.936611,Coronavirus disease - COVID-19,1,0
hsa05017,0.001034926,"1% O2, CyA+ vs 1% O2, CyA-",2.985090868,Spinocerebellar ataxia,0.661317462,0.17959001
hsa04976,9.73E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.011840804,Bile secretion,0.065684511,1.182537031
hsa04060,0.270008752,"1% O2, CyA+ vs 1% O2, CyA-",0.568622158,Cytokine-cytokine receptor interaction,1,0
hsa04925,0.000192934,"1% O2, CyA+ vs 1% O2, CyA-",3.714591817,Aldosterone synthesis and secretion,0.128493871,0.891117588
hsa00280,0.081479975,"1% O2, CyA+ vs 1% O2, CyA-",1.088949114,"Valine, leucine and isoleucine degradation",1,0
hsa00380,0.267333634,"1% O2, CyA+ vs 1% O2, CyA-",0.572946399,Tryptophan metabolism,1,0
hsa04662,0.000391078,"1% O2, CyA+ vs 1% O2, CyA-",3.407736221,B cell receptor signaling pathway,0.255765244,0.592158472
hsa00970,0.039069688,"1% O2, CyA+ vs 1% O2, CyA-",1.408160052,Aminoacyl-tRNA biosynthesis,1,0
hsa04936,0.00106061,"1% O2, CyA+ vs 1% O2, CyA-",2.974444371,Alcoholic liver disease,0.676669042,0.169623692
hsa04923,0.125863181,"1% O2, CyA+ vs 1% O2, CyA-",0.900101298,Regulation of lipolysis in adipocytes,1,0
hsa05215,2.69E-19,"1% O2, CyA+ vs 1% O2, CyA-",18.56995243,Prostate cancer,2.21E-16,15.65560927
hsa05224,4.05E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.392313963,Breast cancer,0.002897291,2.538007921
hsa04014,3.10E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.508522652,Ras signaling pathway,0.021302672,1.671565915
hsa04151,0.060777639,"1% O2, CyA+ vs 1% O2, CyA-",1.216256175,PI3K-Akt signaling pathway,1,0
hsa05417,0.016661121,"1% O2, CyA+ vs 1% O2, CyA-",1.778295783,Lipid and atherosclerosis,1,0
hsa04210,0.018521,"1% O2, CyA+ vs 1% O2, CyA-",1.732335575,Apoptosis,1,0
hsa04713,0.309815437,"1% O2, CyA+ vs 1% O2, CyA-",0.508896947,Circadian entrainment,1,0
hsa05120,0.009676096,"1% O2, CyA+ vs 1% O2, CyA-",2.014299815,Epithelial cell signaling in Helicobacter pylori infection,1,0
hsa00350,0.486077079,"1% O2, CyA+ vs 1% O2, CyA-",0.313294857,Tyrosine metabolism,1,0
hsa05322,0.521375247,"1% O2, CyA+ vs 1% O2, CyA-",0.282849592,Systemic lupus erythematosus,1,0
hsa05163,0.161100339,"1% O2, CyA+ vs 1% O2, CyA-",0.792903546,Human cytomegalovirus infection,1,0
hsa00030,0.055259226,"1% O2, CyA+ vs 1% O2, CyA-",1.257595202,Pentose phosphate pathway,1,0
hsa00230,0.260072848,"1% O2, CyA+ vs 1% O2, CyA-",0.584904986,Purine metabolism,1,0
hsa04211,0.000316384,"1% O2, CyA+ vs 1% O2, CyA-",3.4997856,Longevity regulating pathway,0.208497002,0.680900185
hsa04611,1.81E-10,"1% O2, CyA+ vs 1% O2, CyA-",9.741448516,Platelet activation,1.41E-07,6.851027497
hsa04012,0.000395131,"1% O2, CyA+ vs 1% O2, CyA-",3.40325916,ErbB signaling pathway,0.258020386,0.588345979
hsa04728,0.440557781,"1% O2, CyA+ vs 1% O2, CyA-",0.355997124,Dopaminergic synapse,1,0
hsa05219,0.027039261,"1% O2, CyA+ vs 1% O2, CyA-",1.568005176,Bladder cancer,1,0
hsa00600,5.80E-10,"1% O2, CyA+ vs 1% O2, CyA-",9.236658995,Sphingolipid metabolism,4.46E-07,6.350732655
hsa04972,4.78E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.320993236,Pancreatic secretion,0.003400061,2.468513242
hsa04360,2.66E-16,"1% O2, CyA+ vs 1% O2, CyA-",15.57538607,Axon guidance,2.15E-13,12.66851253
hsa04722,9.27E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.032852116,Neurotrophin signaling pathway,0.000674962,3.170720736
hsa00512,0.532996812,"1% O2, CyA+ vs 1% O2, CyA-",0.273275389,Mucin type O-glycan biosynthesis,1,0
hsa04723,0.164038429,"1% O2, CyA+ vs 1% O2, CyA-",0.785054398,Retrograde endocannabinoid signaling,1,0
hsa00601,0.533457217,"1% O2, CyA+ vs 1% O2, CyA-",0.272900405,Glycosphingolipid biosynthesis - lacto and neolacto series,1,0
hsa05204,0.333992959,"1% O2, CyA+ vs 1% O2, CyA-",0.476262688,Chemical carcinogenesis - DNA adducts,1,0
hsa04071,7.81E-06,"1% O2, CyA+ vs 1% O2, CyA-",5.107402665,Sphingolipid signaling pathway,0.00549756,2.259830006
hsa04213,0.005604093,"1% O2, CyA+ vs 1% O2, CyA-",2.251494643,Longevity regulating pathway - multiple species,1,0
hsa04270,0.020551384,"1% O2, CyA+ vs 1% O2, CyA-",1.687158933,Vascular smooth muscle contraction,1,0
hsa04918,3.21E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.493482804,Thyroid hormone synthesis,0.000235942,3.627195465
hsa04657,0.201275283,"1% O2, CyA+ vs 1% O2, CyA-",0.696209553,IL-17 signaling pathway,1,0
hsa04622,3.89E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.409500142,RIG-I-like receptor signaling pathway,0.026602384,1.575079439
hsa00052,0.073623387,"1% O2, CyA+ vs 1% O2, CyA-",1.132984206,Galactose metabolism,1,0
hsa00515,0.540416265,"1% O2, CyA+ vs 1% O2, CyA-",0.267271588,Mannose type O-glycan biosynthesis,1,0
hsa04659,0.189360983,"1% O2, CyA+ vs 1% O2, CyA-",0.722709501,Th17 cell differentiation,1,0
hsa00270,0.278780574,"1% O2, CyA+ vs 1% O2, CyA-",0.554737492,Cysteine and methionine metabolism,1,0
hsa04915,0.195478417,"1% O2, CyA+ vs 1% O2, CyA-",0.708901186,Estrogen signaling pathway,1,0
hsa04216,0.001350476,"1% O2, CyA+ vs 1% O2, CyA-",2.869513248,Ferroptosis,0.853500599,0.06879617
hsa04512,0.397837364,"1% O2, CyA+ vs 1% O2, CyA-",0.400294432,ECM-receptor interaction,1,0
hsa04510,0.292053472,"1% O2, CyA+ vs 1% O2, CyA-",0.534537626,Focal adhesion,1,0
hsa04668,0.000974803,"1% O2, CyA+ vs 1% O2, CyA-",3.011083262,TNF signaling pathway,0.624848552,0.204225232
hsa05226,0.005353422,"1% O2, CyA+ vs 1% O2, CyA-",2.271368528,Gastric cancer,1,0
hsa00770,0.518037592,"1% O2, CyA+ vs 1% O2, CyA-",0.285638724,Pantothenate and CoA biosynthesis,1,0
hsa05131,8.52E-07,"1% O2, CyA+ vs 1% O2, CyA-",6.069653217,Shigellosis,0.000620975,3.206925688
hsa01522,0.31456187,"1% O2, CyA+ vs 1% O2, CyA-",0.502293922,Endocrine resistance,1,0
hsa04062,0.031004233,"1% O2, CyA+ vs 1% O2, CyA-",1.508579011,Chemokine signaling pathway,1,0
hsa04911,0.144154086,"1% O2, CyA+ vs 1% O2, CyA-",0.841173043,Insulin secretion,1,0
hsa00040,0.481200647,"1% O2, CyA+ vs 1% O2, CyA-",0.317673797,Pentose and glucuronate interconversions,1,0
hsa04930,7.24E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.140276852,Type II diabetes mellitus,0.048940662,1.310330156
hsa05202,1.91E-05,"1% O2, CyA+ vs 1% O2, CyA-",4.719446194,Transcriptional misregulation in cancer,0.013278929,1.876836954
hsa05145,0.246437796,"1% O2, CyA+ vs 1% O2, CyA-",0.608292684,Toxoplasmosis,1,0
hsa04380,0.020981381,"1% O2, CyA+ vs 1% O2, CyA-",1.678165929,Osteoclast differentiation,1,0
hsa04010,0.261264992,"1% O2, CyA+ vs 1% O2, CyA-",0.58291878,MAPK signaling pathway,1,0
hsa05142,0.214991068,"1% O2, CyA+ vs 1% O2, CyA-",0.667579583,Chagas disease,1,0
hsa00020,0.269131247,"1% O2, CyA+ vs 1% O2, CyA-",0.570035876,Citrate cycle (TCA cycle),1,0
hsa04744,0.519282335,"1% O2, CyA+ vs 1% O2, CyA-",0.284596451,Phototransduction,1,0
hsa04921,0.129960968,"1% O2, CyA+ vs 1% O2, CyA-",0.886187063,Oxytocin signaling pathway,1,0
hsa05225,2.86E-08,"1% O2, CyA- vs 19% O2, CyA-",7.543489472,Hepatocellular carcinoma,2.16E-05,4.664967676
hsa04962,0.4727076,"1% O2, CyA- vs 19% O2, CyA-",0.325407415,Vasopressin-regulated water reabsorption,1,0
hsa03250,0,"1% O2, CyA- vs 19% O2, CyA-",Inf,Viral life cycle - HIV-1,0,Inf
hsa04912,8.13E-27,"1% O2, CyA- vs 19% O2, CyA-",26.08990683,GnRH signaling pathway,6.81E-24,23.16666281
hsa05218,5.74E-23,"1% O2, CyA- vs 19% O2, CyA-",22.24082655,Melanoma,4.78E-20,19.32070322
hsa00100,5.06E-14,"1% O2, CyA- vs 19% O2, CyA-",13.29619391,Steroid biosynthesis,4.00E-11,10.39801743
hsa00830,0.474118157,"1% O2, CyA- vs 19% O2, CyA-",0.324113412,Retinol metabolism,1,0
hsa00785,0.553357213,"1% O2, CyA- vs 19% O2, CyA-",0.256994424,Lipoic acid metabolism,1,0
hsa04625,2.48E-15,"1% O2, CyA- vs 19% O2, CyA-",14.60546383,C-type lectin receptor signaling pathway,1.98E-12,11.70346094
hsa05221,0.000780848,"1% O2, CyA- vs 19% O2, CyA-",3.107433436,Acute myeloid leukemia,0.50442788,0.297200918
hsa04145,4.24E-06,"1% O2, CyA- vs 19% O2, CyA-",5.37275614,Phagosome,0.00302651,2.519057929
hsa05217,0.479348131,"1% O2, CyA- vs 19% O2, CyA-",0.319348962,Basal cell carcinoma,1,0
hsa05223,0.116188173,"1% O2, CyA- vs 19% O2, CyA-",0.934838079,Non-small cell lung cancer,1,0
hsa05330,0.54749394,"1% O2, CyA- vs 19% O2, CyA-",0.261620684,Allograft rejection,1,0
hsa04022,0.120699331,"1% O2, CyA- vs 19% O2, CyA-",0.918295137,cGMP-PKG signaling pathway,1,0
hsa00140,0.519371363,"1% O2, CyA- vs 19% O2, CyA-",0.284522,Steroid hormone biosynthesis,1,0
hsa04066,0.021963801,"1% O2, CyA- vs 19% O2, CyA-",1.658292502,HIF-1 signaling pathway,1,0
hsa04724,0.448738071,"1% O2, CyA- vs 19% O2, CyA-",0.348007084,Glutamatergic synapse,1,0
hsa05012,0.326089249,"1% O2, CyA- vs 19% O2, CyA-",0.486663519,Parkinson disease,1,0
hsa05146,0.461775502,"1% O2, CyA- vs 19% O2, CyA-",0.335569111,Amoebiasis,1,0
hsa05410,0.355521694,"1% O2, CyA- vs 19% O2, CyA-",0.449133893,Hypertrophic cardiomyopathy,1,0
hsa00510,0.504438643,"1% O2, CyA- vs 19% O2, CyA-",0.297191651,N-Glycan biosynthesis,1,0
hsa04114,0,"1% O2, CyA- vs 19% O2, CyA-",Inf,Oocyte meiosis,0,Inf
hsa04310,0.028037751,"1% O2, CyA- vs 19% O2, CyA-",1.552256827,Wnt signaling pathway,1,0
hsa03015,5.15E-08,"1% O2, CyA- vs 19% O2, CyA-",7.288092709,mRNA surveillance pathway,3.88E-05,4.411297733
hsa03440,0.099071018,"1% O2, CyA- vs 19% O2, CyA-",1.004053374,Homologous recombination,1,0
hsa05152,0.297030848,"1% O2, CyA- vs 19% O2, CyA-",0.527198444,Tuberculosis,1,0
hsa04110,0.021844613,"1% O2, CyA- vs 19% O2, CyA-",1.660655639,Cell cycle,1,0
hsa00604,0.535845161,"1% O2, CyA- vs 19% O2, CyA-",0.270960687,Glycosphingolipid biosynthesis - ganglio series,1,0
hsa05416,1.54E-15,"1% O2, CyA- vs 19% O2, CyA-",14.81291044,Viral myocarditis,1.23E-12,11.90982045
hsa04664,1.09E-08,"1% O2, CyA- vs 19% O2, CyA-",7.964443028,Fc epsilon RI signaling pathway,8.25E-06,5.083629436
hsa04929,0.001328925,"1% O2, CyA- vs 19% O2, CyA-",2.876499459,GnRH secretion,0.84120966,0.075095749
hsa04136,2.73E-28,"1% O2, CyA- vs 19% O2, CyA-",27.56375984,Autophagy - other,2.30E-25,24.63896385
hsa04660,5.07E-06,"1% O2, CyA- vs 19% O2, CyA-",5.29539234,T cell receptor signaling pathway,0.003591318,2.444746105
hsa00310,0.124978035,"1% O2, CyA- vs 19% O2, CyA-",0.903166309,Lysine degradation,1,0
hsa04070,0.273962848,"1% O2, CyA- vs 19% O2, CyA-",0.562308328,Phosphatidylinositol signaling system,1,0
hsa04726,0.196029097,"1% O2, CyA- vs 19% O2, CyA-",0.70767946,Serotonergic synapse,1,0
hsa05332,0.551165838,"1% O2, CyA- vs 19% O2, CyA-",0.258717709,Graft-versus-host disease,1,0
hsa04916,0.225814623,"1% O2, CyA- vs 19% O2, CyA-",0.646247938,Melanogenesis,1,0
hsa05169,0.180065483,"1% O2, CyA- vs 19% O2, CyA-",0.74456953,Epstein-Barr virus infection,1,0
hsa00900,0.249469306,"1% O2, CyA- vs 19% O2, CyA-",0.602982882,Terpenoid backbone biosynthesis,1,0
hsa00591,0.468567158,"1% O2, CyA- vs 19% O2, CyA-",0.329228154,Linoleic acid metabolism,1,0
hsa04024,0.000694279,"1% O2, CyA- vs 19% O2, CyA-",3.158466019,cAMP signaling pathway,0.449198463,0.347561738
hsa04068,8.82E-19,"1% O2, CyA- vs 19% O2, CyA-",18.05429391,FoxO signaling pathway,7.21E-16,15.14207186
hsa00520,0.37817259,"1% O2, CyA- vs 19% O2, CyA-",0.422309952,Amino sugar and nucleotide sugar metabolism,1,0
hsa00860,0.492727644,"1% O2, CyA- vs 19% O2, CyA-",0.307393071,Porphyrin metabolism,1,0
hsa04922,1.22E-131,"1% O2, CyA- vs 19% O2, CyA-",130.9144807,Glucagon signaling pathway,1.06E-128,127.9729692
hsa04926,0.084094062,"1% O2, CyA- vs 19% O2, CyA-",1.075234671,Relaxin signaling pathway,1,0
hsa04370,0.142498348,"1% O2, CyA- vs 19% O2, CyA-",0.84619017,VEGF signaling pathway,1,0
hsa05213,7.18E-22,"1% O2, CyA- vs 19% O2, CyA-",21.14369432,Endometrial cancer,5.95E-19,18.22513979
hsa04520,6.93E-08,"1% O2, CyA- vs 19% O2, CyA-",7.159231421,Adherens junction,5.20E-05,4.284170158
hsa05110,0.06969509,"1% O2, CyA- vs 19% O2, CyA-",1.156797818,Vibrio cholerae infection,1,0
hsa05220,0.010455475,"1% O2, CyA- vs 19% O2, CyA-",1.980656219,Chronic myeloid leukemia,1,0
hsa05235,0.049861319,"1% O2, CyA- vs 19% O2, CyA-",1.302236241,PD-L1 expression and PD-1 checkpoint pathway in cancer,1,0
hsa05207,2.44E-06,"1% O2, CyA- vs 19% O2, CyA-",5.612093069,Chemical carcinogenesis - receptor activation,0.00175645,2.755364179
hsa05418,0.366488347,"1% O2, CyA- vs 19% O2, CyA-",0.43593983,Fluid shear stress and atherosclerosis,1,0
hsa00920,0.524355211,"1% O2, CyA- vs 19% O2, CyA-",0.280374412,Sulfur metabolism,1,0
hsa04931,0.113539166,"1% O2, CyA- vs 19% O2, CyA-",0.944854298,Insulin resistance,1,0
hsa00500,0.345498858,"1% O2, CyA- vs 19% O2, CyA-",0.461553383,Starch and sucrose metabolism,1,0
hsa05216,0.388999151,"1% O2, CyA- vs 19% O2, CyA-",0.410051346,Thyroid cancer,1,0
hsa00740,0.474257657,"1% O2, CyA- vs 19% O2, CyA-",0.323985649,Riboflavin metabolism,1,0
hsa00062,0.33949196,"1% O2, CyA- vs 19% O2, CyA-",0.469170506,Fatty acid elongation,1,0
hsa04390,0.368917104,"1% O2, CyA- vs 19% O2, CyA-",0.433071209,Hippo signaling pathway,1,0
hsa04064,0.172563692,"1% O2, CyA- vs 19% O2, CyA-",0.763050576,NF-kappa B signaling pathway,1,0
hsa04932,0.000960912,"1% O2, CyA- vs 19% O2, CyA-",3.017316539,Non-alcoholic fatty liver disease,0.616905282,0.209781511
hsa05222,1.05E-11,"1% O2, CyA- vs 19% O2, CyA-",10.97733248,Small cell lung cancer,8.25E-09,8.083570716
hsa05320,0.531326108,"1% O2, CyA- vs 19% O2, CyA-",0.274638843,Autoimmune thyroid disease,1,0
hsa04115,0.355422492,"1% O2, CyA- vs 19% O2, CyA-",0.449255092,p53 signaling pathway,1,0
hsa04710,1.91E-57,"1% O2, CyA- vs 19% O2, CyA-",56.71992157,Circadian rhythm,1.65E-54,53.78340783
hsa05206,5.42E-07,"1% O2, CyA- vs 19% O2, CyA-",6.266303427,MicroRNAs in cancer,0.000396468,3.401792346
hsa05032,0.322095331,"1% O2, CyA- vs 19% O2, CyA-",0.492015571,Morphine addiction,1,0
hsa00620,0.215847604,"1% O2, CyA- vs 19% O2, CyA-",0.665852767,Pyruvate metabolism,1,0
hsa05132,2.54E-30,"1% O2, CyA- vs 19% O2, CyA-",29.59447817,Salmonella infection,2.15E-27,26.66659476
hsa04658,0.332671449,"1% O2, CyA- vs 19% O2, CyA-",0.477984471,Th1 and Th2 cell differentiation,1,0
hsa05014,2.86E-06,"1% O2, CyA- vs 19% O2, CyA-",5.543661246,Amyotrophic lateral sclerosis,0.002047631,2.688748224
hsa04933,0.301538825,"1% O2, CyA- vs 19% O2, CyA-",0.520656762,AGE-RAGE signaling pathway in diabetic complications,1,0
hsa00531,0.519064574,"1% O2, CyA- vs 19% O2, CyA-",0.28477861,Glycosaminoglycan degradation,1,0
hsa04714,0.018258399,"1% O2, CyA- vs 19% O2, CyA-",1.738537297,Thermogenesis,1,0
hsa00592,0.432113,"1% O2, CyA- vs 19% O2, CyA-",0.364402668,alpha-Linolenic acid metabolism,1,0
hsa05170,0.224560798,"1% O2, CyA- vs 19% O2, CyA-",0.648666057,Human immunodeficiency virus 1 infection,1,0
hsa05160,0.197685096,"1% O2, CyA- vs 19% O2, CyA-",0.704026073,Hepatitis C,1,0
hsa04392,0.445555197,"1% O2, CyA- vs 19% O2, CyA-",0.351098486,Hippo signaling pathway - multiple species,1,0
hsa04666,6.58E-05,"1% O2, CyA- vs 19% O2, CyA-",4.181539642,Fc gamma R-mediated phagocytosis,0.044570656,1.350950973
hsa04920,0.027873187,"1% O2, CyA- vs 19% O2, CyA-",1.554813369,Adipocytokine signaling pathway,1,0
hsa04940,0.529405676,"1% O2, CyA- vs 19% O2, CyA-",0.276211407,Type I diabetes mellitus,1,0
hsa04672,0.189796385,"1% O2, CyA- vs 19% O2, CyA-",0.721712063,Intestinal immune network for IgA production,1,0
hsa00780,0.544107571,"1% O2, CyA- vs 19% O2, CyA-",0.264315231,Biotin metabolism,1,0
hsa00590,0.489233773,"1% O2, CyA- vs 19% O2, CyA-",0.31048357,Arachidonic acid metabolism,1,0
hsa05161,0.3404619,"1% O2, CyA- vs 19% O2, CyA-",0.467931481,Hepatitis B,1,0
hsa04540,0.322182678,"1% O2, CyA- vs 19% O2, CyA-",0.491897813,Gap junction,1,0
hsa04913,0.000254255,"1% O2, CyA- vs 19% O2, CyA-",3.59473064,Ovarian steroidogenesis,0.1680625,0.774529181
hsa05212,0.080788575,"1% O2, CyA- vs 19% O2, CyA-",1.09265005,Pancreatic cancer,1,0
hsa05211,3.52E-40,"1% O2, CyA- vs 19% O2, CyA-",39.45322924,Renal cell carcinoma,3.01E-37,36.52075548
hsa04371,0.003995328,"1% O2, CyA- vs 19% O2, CyA-",2.398447601,Apelin signaling pathway,1,0
hsa05164,0.043372477,"1% O2, CyA- vs 19% O2, CyA-",1.36278577,Influenza A,1,0
hsa04146,0.360878621,"1% O2, CyA- vs 19% O2, CyA-",0.442638846,Peroxisome,1,0
hsa04122,1.79E-08,"1% O2, CyA- vs 19% O2, CyA-",7.747561179,Sulfur relay system,1.35E-05,4.868465299
hsa05167,0.035776225,"1% O2, CyA- vs 19% O2, CyA-",1.446405481,Kaposi sarcoma-associated herpesvirus infection,1,0
hsa00562,0.053210073,"1% O2, CyA- vs 19% O2, CyA-",1.274006149,Inositol phosphate metabolism,1,0
hsa04935,0.173740877,"1% O2, CyA- vs 19% O2, CyA-",0.760097992,"Growth hormone synthesis, secretion and action",1,0
hsa00240,0.178991908,"1% O2, CyA- vs 19% O2, CyA-",0.747166602,Pyrimidine metabolism,1,0
hsa05200,0.083538818,"1% O2, CyA- vs 19% O2, CyA-",1.078111672,Pathways in cancer,1,0
hsa00480,0.480416342,"1% O2, CyA- vs 19% O2, CyA-",0.318382228,Glutathione metabolism,1,0
hsa04150,8.48E-20,"1% O2, CyA- vs 19% O2, CyA-",19.0713644,mTOR signaling pathway,6.99E-17,16.15543719
hsa05034,5.52E-15,"1% O2, CyA- vs 19% O2, CyA-",14.25780623,Alcoholism,4.40E-12,11.35689316
hsa04750,0.23946079,"1% O2, CyA- vs 19% O2, CyA-",0.620765589,Inflammatory mediator regulation of TRP channels,1,0
hsa04137,0.001393247,"1% O2, CyA- vs 19% O2, CyA-",2.855971998,Mitophagy - animal,0.879138626,0.055942638
hsa05203,1.09E-06,"1% O2, CyA- vs 19% O2, CyA-",5.964493048,Viral carcinogenesis,0.000786765,3.104155042
hsa03320,0.485034706,"1% O2, CyA- vs 19% O2, CyA-",0.314227185,PPAR signaling pathway,1,0
hsa00564,0.450431464,"1% O2, CyA- vs 19% O2, CyA-",0.34637128,Glycerophospholipid metabolism,1,0
hsa04961,0.489623267,"1% O2, CyA- vs 19% O2, CyA-",0.310137953,Endocrine and other factor-regulated calcium reabsorption,1,0
hsa00220,0.435052725,"1% O2, CyA- vs 19% O2, CyA-",0.361458106,Arginine biosynthesis,1,0
hsa05168,0.204204902,"1% O2, CyA- vs 19% O2, CyA-",0.689933837,Herpes simplex virus 1 infection,1,0
hsa04061,0.000120465,"1% O2, CyA- vs 19% O2, CyA-",3.919138327,Viral protein interaction with cytokine and cytokine receptor,0.080832162,1.092415807
hsa05412,0.173272098,"1% O2, CyA- vs 19% O2, CyA-",0.761271366,Arrhythmogenic right ventricular cardiomyopathy,1,0
hsa04924,0.416707495,"1% O2, CyA- vs 19% O2, CyA-",0.380168688,Renin secretion,1,0
hsa05143,0.482057947,"1% O2, CyA- vs 19% O2, CyA-",0.316900754,African trypanosomiasis,1,0
hsa04960,0.184127602,"1% O2, CyA- vs 19% O2, CyA-",0.734881102,Aldosterone-regulated sodium reabsorption,1,0
hsa05162,0.134306469,"1% O2, CyA- vs 19% O2, CyA-",0.871903069,Measles,1,0
hsa00730,0.50230754,"1% O2, CyA- vs 19% O2, CyA-",0.299030302,Thiamine metabolism,1,0
hsa05030,0.196151999,"1% O2, CyA- vs 19% O2, CyA-",0.707407261,Cocaine addiction,1,0
hsa00750,0.502442874,"1% O2, CyA- vs 19% O2, CyA-",0.298913309,Vitamin B6 metabolism,1,0
hsa04623,0.014691371,"1% O2, CyA- vs 19% O2, CyA-",1.832937666,Cytosolic DNA-sensing pathway,1,0
hsa00650,0.2790217,"1% O2, CyA- vs 19% O2, CyA-",0.554362019,Butanoate metabolism,1,0
hsa05010,0.012377907,"1% O2, CyA- vs 19% O2, CyA-",1.90735277,Alzheimer disease,1,0
hsa05031,6.95E-06,"1% O2, CyA- vs 19% O2, CyA-",5.15806519,Amphetamine addiction,0.004899186,2.309876073
hsa00071,0.063924911,"1% O2, CyA- vs 19% O2, CyA-",1.194329866,Fatty acid degradation,1,0
hsa00561,0.475569028,"1% O2, CyA- vs 19% O2, CyA-",0.322786437,Glycerolipid metabolism,1,0
hsa04614,0.483952094,"1% O2, CyA- vs 19% O2, CyA-",0.315197626,Renin-angiotensin system,1,0
hsa04971,0.054495401,"1% O2, CyA- vs 19% O2, CyA-",1.263640147,Gastric acid secretion,1,0
hsa04215,3.80E-14,"1% O2, CyA- vs 19% O2, CyA-",13.42060168,Apoptosis - multiple species,3.01E-11,10.5218765
hsa04080,0.365439198,"1% O2, CyA- vs 19% O2, CyA-",0.437184871,Neuroactive ligand-receptor interaction,1,0
hsa05231,0.030572521,"1% O2, CyA- vs 19% O2, CyA-",1.514668752,Choline metabolism in cancer,1,0
hsa05166,0.003881559,"1% O2, CyA- vs 19% O2, CyA-",2.410993834,Human T-cell leukemia virus 1 infection,1,0
hsa00790,0.420729963,"1% O2, CyA- vs 19% O2, CyA-",0.375996558,Folate biosynthesis,1,0
hsa00983,0.383536075,"1% O2, CyA- vs 19% O2, CyA-",0.41619378,Drug metabolism - other enzymes,1,0
hsa04721,0.105837948,"1% O2, CyA- vs 19% O2, CyA-",0.975358589,Synaptic vesicle cycle,1,0
hsa04218,1.40E-166,"1% O2, CyA- vs 19% O2, CyA-",165.8547907,Cellular senescence,1.23E-163,162.9117911
hsa04530,0.005123337,"1% O2, CyA- vs 19% O2, CyA-",2.290447047,Tight junction,1,0
hsa04340,0.22749017,"1% O2, CyA- vs 19% O2, CyA-",0.643037365,Hedgehog signaling pathway,1,0
hsa04725,8.79E-10,"1% O2, CyA- vs 19% O2, CyA-",9.055947536,Cholinergic synapse,6.75E-07,6.170586316
hsa04740,0.52191497,"1% O2, CyA- vs 19% O2, CyA-",0.282400246,Olfactory transduction,1,0
hsa04152,1.01E-22,"1% O2, CyA- vs 19% O2, CyA-",21.99524639,AMPK signaling pathway,8.40E-20,19.07564536
hsa03460,0.000612251,"1% O2, CyA- vs 19% O2, CyA-",3.213070428,Fanconi anemia pathway,0.397350962,0.400825732
hsa05214,0.005762903,"1% O2, CyA- vs 19% O2, CyA-",2.239358687,Glioma,1,0
hsa00440,0.535768923,"1% O2, CyA- vs 19% O2, CyA-",0.271022481,Phosphonate and phosphinate metabolism,1,0
hsa04020,0.439000811,"1% O2, CyA- vs 19% O2, CyA-",0.357534678,Calcium signaling pathway,1,0
hsa04514,0.055960756,"1% O2, CyA- vs 19% O2, CyA-",1.25211643,Cell adhesion molecules,1,0
hsa04613,0.023914085,"1% O2, CyA- vs 19% O2, CyA-",1.621346228,Neutrophil extracellular trap formation,1,0
hsa00250,0.421023792,"1% O2, CyA- vs 19% O2, CyA-",0.375693361,"Alanine, aspartate and glutamate metabolism",1,0
hsa04217,0.016587089,"1% O2, CyA- vs 19% O2, CyA-",1.780229835,Necroptosis,1,0
hsa04934,3.01E-16,"1% O2, CyA- vs 19% O2, CyA-",15.52193177,Cushing syndrome,2.42E-13,12.61559673
hsa05140,1.30E-08,"1% O2, CyA- vs 19% O2, CyA-",7.885492565,Leishmaniasis,9.88E-06,5.005250789
hsa04919,2.95E-07,"1% O2, CyA- vs 19% O2, CyA-",6.530659412,Thyroid hormone signaling pathway,0.000217174,3.663191924
hsa04550,0.014193664,"1% O2, CyA- vs 19% O2, CyA-",1.84790548,Signaling pathways regulating pluripotency of stem cells,1,0
hsa00061,0.005698544,"1% O2, CyA- vs 19% O2, CyA-",2.244236086,Fatty acid biosynthesis,1,0
hsa00532,0.515091198,"1% O2, CyA- vs 19% O2, CyA-",0.288115871,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0
hsa04742,0.311899995,"1% O2, CyA- vs 19% O2, CyA-",0.505984632,Taste transduction,1,0
hsa04261,0.221318141,"1% O2, CyA- vs 19% O2, CyA-",0.654982986,Adrenergic signaling in cardiomyocytes,1,0
hsa04910,0.119345742,"1% O2, CyA- vs 19% O2, CyA-",0.923193072,Insulin signaling pathway,1,0
hsa04015,1.66E-08,"1% O2, CyA- vs 19% O2, CyA-",7.778759496,Rap1 signaling pathway,1.26E-05,4.899090291
hsa05208,0.034653196,"1% O2, CyA- vs 19% O2, CyA-",1.460256709,Chemical carcinogenesis - reactive oxygen species,1,0
hsa04914,1.84E-159,"1% O2, CyA- vs 19% O2, CyA-",158.7354447,Progesterone-mediated oocyte maturation,1.61E-156,155.7929406
hsa04130,0.231609848,"1% O2, CyA- vs 19% O2, CyA-",0.635242979,SNARE interactions in vesicular transport,1,0
hsa00640,4.56E-20,"1% O2, CyA- vs 19% O2, CyA-",19.34110744,Propanoate metabolism,3.76E-17,16.42465349
hsa00450,0.45097895,"1% O2, CyA- vs 19% O2, CyA-",0.345843729,Selenocompound metabolism,1,0
hsa04621,1.13E-06,"1% O2, CyA- vs 19% O2, CyA-",5.945783717,NOD-like receptor signaling pathway,0.000820266,3.08604515
hsa05130,0.000898667,"1% O2, CyA- vs 19% O2, CyA-",3.046401232,Pathogenic Escherichia coli infection,0.578741513,0.237515365
hsa04670,0.215140136,"1% O2, CyA- vs 19% O2, CyA-",0.667278561,Leukocyte transendothelial migration,1,0
hsa04928,1.41E-10,"1% O2, CyA- vs 19% O2, CyA-",9.850971237,"Parathyroid hormone synthesis, secretion and action",1.10E-07,6.95999164
hsa00130,0.408622882,"1% O2, CyA- vs 19% O2, CyA-",0.388677318,Ubiquinone and other terpenoid-quinone biosynthesis,1,0
hsa05100,0.065809956,"1% O2, CyA- vs 19% O2, CyA-",1.181708399,Bacterial invasion of epithelial cells,1,0
hsa05414,0.329014527,"1% O2, CyA- vs 19% O2, CyA-",0.482784926,Dilated cardiomyopathy,1,0
hsa05321,0.491118921,"1% O2, CyA- vs 19% O2, CyA-",0.308813334,Inflammatory bowel disease,1,0
hsa00051,0.338699969,"1% O2, CyA- vs 19% O2, CyA-",0.470184843,Fructose and mannose metabolism,1,0
hsa05230,4.28E-17,"1% O2, CyA- vs 19% O2, CyA-",16.3685667,Central carbon metabolism in cancer,3.48E-14,13.45901067
hsa04727,0.003131648,"1% O2, CyA- vs 19% O2, CyA-",2.504227014,GABAergic synapse,1,0
hsa04630,0.383045982,"1% O2, CyA- vs 19% O2, CyA-",0.416749089,JAK-STAT signaling pathway,1,0
hsa00603,0.52324813,"1% O2, CyA- vs 19% O2, CyA-",0.281292315,Glycosphingolipid biosynthesis - globo and isoglobo series,1,0
hsa00340,0.519892938,"1% O2, CyA- vs 19% O2, CyA-",0.284086082,Histidine metabolism,1,0
hsa04610,0.350896129,"1% O2, CyA- vs 19% O2, CyA-",0.454821423,Complement and coagulation cascades,1,0
hsa05205,0.078797398,"1% O2, CyA- vs 19% O2, CyA-",1.103488121,Proteoglycans in cancer,1,0
hsa04140,1.25E-52,"1% O2, CyA- vs 19% O2, CyA-",51.90396453,Autophagy - animal,1.08E-49,48.96795373
hsa00010,0.444467122,"1% O2, CyA- vs 19% O2, CyA-",0.352160359,Glycolysis / Gluconeogenesis,1,0
hsa04144,5.48E-07,"1% O2, CyA- vs 19% O2, CyA-",6.261490476,Endocytosis,0.000400338,3.397573099
hsa01521,0,"1% O2, CyA- vs 19% O2, CyA-",Inf,EGFR tyrosine kinase inhibitor resistance,0,Inf
hsa05415,0.2308997,"1% O2, CyA- vs 19% O2, CyA-",0.636576632,Diabetic cardiomyopathy,1,0
hsa05133,0.309846031,"1% O2, CyA- vs 19% O2, CyA-",0.508854062,Pertussis,1,0
hsa04620,0.104140747,"1% O2, CyA- vs 19% O2, CyA-",0.98237931,Toll-like receptor signaling pathway,1,0
hsa00980,0.485926965,"1% O2, CyA- vs 19% O2, CyA-",0.313429,Metabolism of xenobiotics by cytochrome P450,1,0
hsa01524,1.86E-12,"1% O2, CyA- vs 19% O2, CyA-",11.73083257,Platinum drug resistance,1.46E-09,8.834857839
hsa00630,0.423159966,"1% O2, CyA- vs 19% O2, CyA-",0.373495426,Glyoxylate and dicarboxylate metabolism,1,0
hsa05022,0.069720123,"1% O2, CyA- vs 19% O2, CyA-",1.156641858,Pathways of neurodegeneration - multiple diseases,1,0
hsa05165,0.380187427,"1% O2, CyA- vs 19% O2, CyA-",0.42000225,Human papillomavirus infection,1,0
hsa04330,0.056302744,"1% O2, CyA- vs 19% O2, CyA-",1.24947044,Notch signaling pathway,1,0
hsa04927,0.0262868,"1% O2, CyA- vs 19% O2, CyA-",1.580262286,Cortisol synthesis and secretion,1,0
hsa01523,0.192406739,"1% O2, CyA- vs 19% O2, CyA-",0.715779722,Antifolate resistance,1,0
hsa05323,0.505025616,"1% O2, CyA- vs 19% O2, CyA-",0.296686593,Rheumatoid arthritis,1,0
hsa00563,0.518895068,"1% O2, CyA- vs 19% O2, CyA-",0.284920457,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1,0
hsa04917,0.068340407,"1% O2, CyA- vs 19% O2, CyA-",1.165322439,Prolactin signaling pathway,1,0
hsa05135,0.237866689,"1% O2, CyA- vs 19% O2, CyA-",0.623666372,Yersinia infection,1,0
hsa04612,0.172229121,"1% O2, CyA- vs 19% O2, CyA-",0.763893415,Antigen processing and presentation,1,0
hsa00330,0.474068939,"1% O2, CyA- vs 19% O2, CyA-",0.324158498,Arginine and proline metabolism,1,0
hsa05016,4.32E-13,"1% O2, CyA- vs 19% O2, CyA-",12.36453556,Huntington disease,3.41E-10,9.467458555
hsa04141,2.00E-18,"1% O2, CyA- vs 19% O2, CyA-",17.69823969,Protein processing in endoplasmic reticulum,1.63E-15,14.78708208
hsa04979,0.035894024,"1% O2, CyA- vs 19% O2, CyA-",1.444977848,Cholesterol metabolism,1,0
hsa00670,0.37403566,"1% O2, CyA- vs 19% O2, CyA-",0.427086991,One carbon pool by folate,1,0
hsa00260,0.504841693,"1% O2, CyA- vs 19% O2, CyA-",0.296844785,"Glycine, serine and threonine metabolism",1,0
hsa04730,0,"1% O2, CyA- vs 19% O2, CyA-",Inf,Long-term depression,0,Inf
hsa04650,2.46E-19,"1% O2, CyA- vs 19% O2, CyA-",18.60879315,Natural killer cell mediated cytotoxicity,2.02E-16,15.69392133
hsa04720,1.87E-10,"1% O2, CyA- vs 19% O2, CyA-",9.727194333,Long-term potentiation,1.45E-07,6.837332611
hsa00360,0.536022812,"1% O2, CyA- vs 19% O2, CyA-",0.270816727,Phenylalanine metabolism,1,0
hsa05020,1.05E-06,"1% O2, CyA- vs 19% O2, CyA-",5.977170193,Prion disease,0.000765185,3.116233572
hsa00760,0.471228588,"1% O2, CyA- vs 19% O2, CyA-",0.32676837,Nicotinate and nicotinamide metabolism,1,0
hsa05210,0.091176151,"1% O2, CyA- vs 19% O2, CyA-",1.040118744,Colorectal cancer,1,0
hsa03018,0.028210211,"1% O2, CyA- vs 19% O2, CyA-",1.549593659,RNA degradation,1,0
hsa00410,0.444667521,"1% O2, CyA- vs 19% O2, CyA-",0.351964591,beta-Alanine metabolism,1,0
hsa00565,0.501958087,"1% O2, CyA- vs 19% O2, CyA-",0.299332545,Ether lipid metabolism,1,0
hsa04350,0.040905178,"1% O2, CyA- vs 19% O2, CyA-",1.388221716,TGF-beta signaling pathway,1,0
hsa05150,0.431089858,"1% O2, CyA- vs 19% O2, CyA-",0.365432194,Staphylococcus aureus infection,1,0
hsa00120,0.531315007,"1% O2, CyA- vs 19% O2, CyA-",0.274647918,Primary bile acid biosynthesis,1,0
hsa04810,8.36E-99,"1% O2, CyA- vs 19% O2, CyA-",98.0778451,Regulation of actin cytoskeleton,7.28E-96,95.13782694
hsa05144,0.483383265,"1% O2, CyA- vs 19% O2, CyA-",0.315708389,Malaria,1,0
hsa04072,4.48E-21,"1% O2, CyA- vs 19% O2, CyA-",20.34916779,Phospholipase D signaling pathway,3.71E-18,17.43113745
hsa00910,1.80E-18,"1% O2, CyA- vs 19% O2, CyA-",17.74462502,Nitrogen metabolism,1.47E-15,14.83293487
hsa00513,0.361567228,"1% O2, CyA- vs 19% O2, CyA-",0.44181094,Various types of N-glycan biosynthesis,1,0
hsa05134,0.357353558,"1% O2, CyA- vs 19% O2, CyA-",0.446901889,Legionellosis,1,0
hsa04970,0.093245271,"1% O2, CyA- vs 19% O2, CyA-",1.030373185,Salivary secretion,1,0
hsa05171,0.22959471,"1% O2, CyA- vs 19% O2, CyA-",0.639038123,Coronavirus disease - COVID-19,1,0
hsa05017,0.135125646,"1% O2, CyA- vs 19% O2, CyA-",0.869262215,Spinocerebellar ataxia,1,0
hsa04976,0.036420607,"1% O2, CyA- vs 19% O2, CyA-",1.438652817,Bile secretion,1,0
hsa04060,0.034394916,"1% O2, CyA- vs 19% O2, CyA-",1.463505743,Cytokine-cytokine receptor interaction,1,0
hsa04925,2.52E-14,"1% O2, CyA- vs 19% O2, CyA-",13.59789533,Aldosterone synthesis and secretion,2.01E-11,10.6975282
hsa00280,1.99E-28,"1% O2, CyA- vs 19% O2, CyA-",27.70139779,"Valine, leucine and isoleucine degradation",1.67E-25,24.7760857
hsa00380,0.348590018,"1% O2, CyA- vs 19% O2, CyA-",0.457685053,Tryptophan metabolism,1,0
hsa04662,0.038214838,"1% O2, CyA- vs 19% O2, CyA-",1.417767981,B cell receptor signaling pathway,1,0
hsa00970,0.236094248,"1% O2, CyA- vs 19% O2, CyA-",0.626914593,Aminoacyl-tRNA biosynthesis,1,0
hsa04936,0.253248616,"1% O2, CyA- vs 19% O2, CyA-",0.59645292,Alcoholic liver disease,1,0
hsa04923,0.455559506,"1% O2, CyA- vs 19% O2, CyA-",0.341454887,Regulation of lipolysis in adipocytes,1,0
hsa05215,0.114110876,"1% O2, CyA- vs 19% O2, CyA-",0.942672961,Prostate cancer,1,0
hsa05224,0.270492343,"1% O2, CyA- vs 19% O2, CyA-",0.567845024,Breast cancer,1,0
hsa04014,2.75E-07,"1% O2, CyA- vs 19% O2, CyA-",6.560597032,Ras signaling pathway,0.000202983,3.692540671
hsa04151,1.86E-05,"1% O2, CyA- vs 19% O2, CyA-",4.73127468,PI3K-Akt signaling pathway,0.01294071,1.888041902
hsa05417,0.142393203,"1% O2, CyA- vs 19% O2, CyA-",0.846510742,Lipid and atherosclerosis,1,0
hsa04210,0.003948568,"1% O2, CyA- vs 19% O2, CyA-",2.403560366,Apoptosis,1,0
hsa04713,2.47E-15,"1% O2, CyA- vs 19% O2, CyA-",14.60763446,Circadian entrainment,1.97E-12,11.70508768
hsa05120,0.260674314,"1% O2, CyA- vs 19% O2, CyA-",0.58390176,Epithelial cell signaling in Helicobacter pylori infection,1,0
hsa00350,0.483833664,"1% O2, CyA- vs 19% O2, CyA-",0.315303918,Tyrosine metabolism,1,0
hsa05322,0.529094285,"1% O2, CyA- vs 19% O2, CyA-",0.276466929,Systemic lupus erythematosus,1,0
hsa05163,0.050147485,"1% O2, CyA- vs 19% O2, CyA-",1.299750846,Human cytomegalovirus infection,1,0
hsa00030,3.02E-05,"1% O2, CyA- vs 19% O2, CyA-",4.519615021,Pentose phosphate pathway,0.020795694,1.682026583
hsa00230,0.456343171,"1% O2, CyA- vs 19% O2, CyA-",0.340708444,Purine metabolism,1,0
hsa04211,0,"1% O2, CyA- vs 19% O2, CyA-",Inf,Longevity regulating pathway,0,Inf
hsa04611,0.088353707,"1% O2, CyA- vs 19% O2, CyA-",1.053775226,Platelet activation,1,0
hsa04012,0.06780467,"1% O2, CyA- vs 19% O2, CyA-",1.168740391,ErbB signaling pathway,1,0
hsa04728,0.362846602,"1% O2, CyA- vs 19% O2, CyA-",0.440276939,Dopaminergic synapse,1,0
hsa05219,0.405514545,"1% O2, CyA- vs 19% O2, CyA-",0.391993563,Bladder cancer,1,0
hsa00600,0.142473604,"1% O2, CyA- vs 19% O2, CyA-",0.846265591,Sphingolipid metabolism,1,0
hsa04972,0.023822819,"1% O2, CyA- vs 19% O2, CyA-",1.623006848,Pancreatic secretion,1,0
hsa04360,2.20E-11,"1% O2, CyA- vs 19% O2, CyA-",10.65739581,Axon guidance,1.72E-08,7.764189055
hsa04722,0.087532436,"1% O2, CyA- vs 19% O2, CyA-",1.057830983,Neurotrophin signaling pathway,1,0
hsa00512,0.533620883,"1% O2, CyA- vs 19% O2, CyA-",0.272767183,Mucin type O-glycan biosynthesis,1,0
hsa04723,0.480137815,"1% O2, CyA- vs 19% O2, CyA-",0.318634088,Retrograde endocannabinoid signaling,1,0
hsa00601,0.522083573,"1% O2, CyA- vs 19% O2, CyA-",0.282259971,Glycosphingolipid biosynthesis - lacto and neolacto series,1,0
hsa05204,0.26118625,"1% O2, CyA- vs 19% O2, CyA-",0.58304969,Chemical carcinogenesis - DNA adducts,1,0
hsa04071,5.90E-26,"1% O2, CyA- vs 19% O2, CyA-",25.22950555,Sphingolipid signaling pathway,4.92E-23,22.30781908
hsa04213,4.14E-12,"1% O2, CyA- vs 19% O2, CyA-",11.38292411,Longevity regulating pathway - multiple species,3.25E-09,8.488054449
hsa04270,6.88E-08,"1% O2, CyA- vs 19% O2, CyA-",7.162651908,Vascular smooth muscle contraction,5.16E-05,4.287011971
hsa04918,0.001101932,"1% O2, CyA- vs 19% O2, CyA-",2.957845052,Thyroid hormone synthesis,0.70193093,0.15370562
hsa04657,0.416042534,"1% O2, CyA- vs 19% O2, CyA-",0.380862267,IL-17 signaling pathway,1,0
hsa04622,0.119211742,"1% O2, CyA- vs 19% O2, CyA-",0.923680967,RIG-I-like receptor signaling pathway,1,0
hsa00052,0.360723436,"1% O2, CyA- vs 19% O2, CyA-",0.442825641,Galactose metabolism,1,0
hsa00515,0.54304596,"1% O2, CyA- vs 19% O2, CyA-",0.265163413,Mannose type O-glycan biosynthesis,1,0
hsa04659,0.19560492,"1% O2, CyA- vs 19% O2, CyA-",0.708620225,Th17 cell differentiation,1,0
hsa00270,0.078462761,"1% O2, CyA- vs 19% O2, CyA-",1.105336416,Cysteine and methionine metabolism,1,0
hsa04915,0.081793711,"1% O2, CyA- vs 19% O2, CyA-",1.087280088,Estrogen signaling pathway,1,0
hsa04216,0.276294945,"1% O2, CyA- vs 19% O2, CyA-",0.55862706,Ferroptosis,1,0
hsa04512,0.368780271,"1% O2, CyA- vs 19% O2, CyA-",0.43323232,ECM-receptor interaction,1,0
hsa04510,3.64E-10,"1% O2, CyA- vs 19% O2, CyA-",9.438941859,Focal adhesion,2.81E-07,6.551324559
hsa04668,3.07E-10,"1% O2, CyA- vs 19% O2, CyA-",9.513438547,TNF signaling pathway,2.37E-07,6.624697586
hsa05226,5.40E-05,"1% O2, CyA- vs 19% O2, CyA-",4.267714942,Gastric cancer,0.036764797,1.43456783
hsa00770,0.522691693,"1% O2, CyA- vs 19% O2, CyA-",0.281754402,Pantothenate and CoA biosynthesis,1,0
hsa05131,0.07417849,"1% O2, CyA- vs 19% O2, CyA-",1.12972201,Shigellosis,1,0
hsa01522,4.98E-06,"1% O2, CyA- vs 19% O2, CyA-",5.302988382,Endocrine resistance,0.003534028,2.451730033
hsa04062,0.1878473,"1% O2, CyA- vs 19% O2, CyA-",0.726195042,Chemokine signaling pathway,1,0
hsa04911,2.15E-06,"1% O2, CyA- vs 19% O2, CyA-",5.667954252,Insulin secretion,0.001546601,2.810621756
hsa00040,0.531070078,"1% O2, CyA- vs 19% O2, CyA-",0.274848167,Pentose and glucuronate interconversions,1,0
hsa04930,0.022999389,"1% O2, CyA- vs 19% O2, CyA-",1.638283705,Type II diabetes mellitus,1,0
hsa05202,0.000258235,"1% O2, CyA- vs 19% O2, CyA-",3.587985221,Transcriptional misregulation in cancer,0.170434973,0.768441285
hsa05145,0.030476776,"1% O2, CyA- vs 19% O2, CyA-",1.51603098,Toxoplasmosis,1,0
hsa04380,0.014328231,"1% O2, CyA- vs 19% O2, CyA-",1.843807433,Osteoclast differentiation,1,0
hsa04010,0.021190894,"1% O2, CyA- vs 19% O2, CyA-",1.673850728,MAPK signaling pathway,1,0
hsa05142,0.476662881,"1% O2, CyA- vs 19% O2, CyA-",0.321788666,Chagas disease,1,0
hsa00020,0.29832515,"1% O2, CyA- vs 19% O2, CyA-",0.525310132,Citrate cycle (TCA cycle),1,0
hsa04744,0.511658778,"1% O2, CyA- vs 19% O2, CyA-",0.291019571,Phototransduction,1,0
hsa04921,0.242882806,"1% O2, CyA- vs 19% O2, CyA-",0.614603229,Oxytocin signaling pathway,1,0
hsa05225,0.005106065,"19% O2, CyA- vs 1% O2, CyA+",2.291913675,Hepatocellular carcinoma,1,0
hsa04962,0.49565353,"19% O2, CyA- vs 1% O2, CyA+",0.304821797,Vasopressin-regulated water reabsorption,1,0
hsa03250,7.23E-91,"19% O2, CyA- vs 1% O2, CyA+",90.14090988,Viral life cycle - HIV-1,6.29E-88,87.20139063
hsa04912,6.29E-09,"19% O2, CyA- vs 1% O2, CyA+",8.20108961,GnRH signaling pathway,4.81E-06,5.317996251
hsa05218,2.58E-14,"19% O2, CyA- vs 1% O2, CyA+",13.58835841,Melanoma,2.05E-11,10.6885379
hsa00100,2.63E-05,"19% O2, CyA- vs 1% O2, CyA+",4.579385891,Steroid biosynthesis,0.018148191,1.741166669
hsa00830,0.50117847,"19% O2, CyA- vs 1% O2, CyA+",0.300007594,Retinol metabolism,1,0
hsa00785,0.517587074,"19% O2, CyA- vs 1% O2, CyA+",0.286016578,Lipoic acid metabolism,1,0
hsa04625,0.132203449,"19% O2, CyA- vs 1% O2, CyA+",0.878757213,C-type lectin receptor signaling pathway,1,0
hsa05221,0.001268197,"19% O2, CyA- vs 1% O2, CyA+",2.896813135,Acute myeloid leukemia,0.804037163,0.094723878
hsa04145,1.12E-16,"19% O2, CyA- vs 1% O2, CyA+",15.94973215,Phagosome,9.07E-14,13.04232079
hsa05217,0.490567377,"19% O2, CyA- vs 1% O2, CyA+",0.309301336,Basal cell carcinoma,1,0
hsa05223,0.015226217,"19% O2, CyA- vs 1% O2, CyA+",1.817407984,Non-small cell lung cancer,1,0
hsa05330,0.542351931,"19% O2, CyA- vs 1% O2, CyA+",0.265718809,Allograft rejection,1,0
hsa04022,0.311849109,"19% O2, CyA- vs 1% O2, CyA+",0.506055492,cGMP-PKG signaling pathway,1,0
hsa00140,0.500003236,"19% O2, CyA- vs 1% O2, CyA+",0.301027185,Steroid hormone biosynthesis,1,0
hsa04066,0.016601609,"19% O2, CyA- vs 1% O2, CyA+",1.779849813,HIF-1 signaling pathway,1,0
hsa04724,0.492849647,"19% O2, CyA- vs 1% O2, CyA+",0.30728555,Glutamatergic synapse,1,0
hsa05012,0.264912468,"19% O2, CyA- vs 1% O2, CyA+",0.576897602,Parkinson disease,1,0
hsa05146,0.365322869,"19% O2, CyA- vs 1% O2, CyA+",0.43732314,Amoebiasis,1,0
hsa05410,0.410909892,"19% O2, CyA- vs 1% O2, CyA+",0.386253404,Hypertrophic cardiomyopathy,1,0
hsa00510,0.499495995,"19% O2, CyA- vs 1% O2, CyA+",0.30146799,N-Glycan biosynthesis,1,0
hsa04114,0.004164936,"19% O2, CyA- vs 1% O2, CyA+",2.380391712,Oocyte meiosis,1,0
hsa04310,0.029033501,"19% O2, CyA- vs 1% O2, CyA+",1.537100598,Wnt signaling pathway,1,0
hsa03015,3.66E-27,"19% O2, CyA- vs 1% O2, CyA+",26.43682638,mRNA surveillance pathway,3.07E-24,23.51306442
hsa03440,0.013688435,"19% O2, CyA- vs 1% O2, CyA+",1.863646192,Homologous recombination,1,0
hsa05152,1.27E-06,"19% O2, CyA- vs 1% O2, CyA+",5.897813194,Tuberculosis,0.000914798,3.038674897
hsa04110,2.67E-33,"19% O2, CyA- vs 1% O2, CyA+",32.57318814,Cell cycle,2.28E-30,29.64274855
hsa00604,0.51803642,"19% O2, CyA- vs 1% O2, CyA+",0.285639707,Glycosphingolipid biosynthesis - ganglio series,1,0
hsa05416,3.31E-50,"19% O2, CyA- vs 1% O2, CyA+",49.47977676,Viral myocarditis,2.86E-47,46.54426949
hsa04664,0,"19% O2, CyA- vs 1% O2, CyA+",Inf,Fc epsilon RI signaling pathway,0,Inf
hsa04929,0.229078166,"19% O2, CyA- vs 1% O2, CyA+",0.640016302,GnRH secretion,1,0
hsa04136,0,"19% O2, CyA- vs 1% O2, CyA+",Inf,Autophagy - other,0,Inf
hsa04660,0.000349281,"19% O2, CyA- vs 1% O2, CyA+",3.456825517,T cell receptor signaling pathway,0.229477364,0.639260148
hsa00310,0.022041531,"19% O2, CyA- vs 1% O2, CyA+",1.656758251,Lysine degradation,1,0
hsa04070,0.009940011,"19% O2, CyA- vs 1% O2, CyA+",2.002613121,Phosphatidylinositol signaling system,1,0
hsa04726,0.086803483,"19% O2, CyA- vs 1% O2, CyA+",1.061462848,Serotonergic synapse,1,0
hsa05332,0.548845733,"19% O2, CyA- vs 1% O2, CyA+",0.260549708,Graft-versus-host disease,1,0
hsa04916,0.466398669,"19% O2, CyA- vs 1% O2, CyA+",0.331242698,Melanogenesis,1,0
hsa05169,0.226104037,"19% O2, CyA- vs 1% O2, CyA+",0.645691684,Epstein-Barr virus infection,1,0
hsa00900,0.26089947,"19% O2, CyA- vs 1% O2, CyA+",0.583526803,Terpenoid backbone biosynthesis,1,0
hsa00591,0.528383457,"19% O2, CyA- vs 1% O2, CyA+",0.277050788,Linoleic acid metabolism,1,0
hsa04024,0.216699583,"19% O2, CyA- vs 1% O2, CyA+",0.664141925,cAMP signaling pathway,1,0
hsa04068,6.63E-31,"19% O2, CyA- vs 1% O2, CyA+",30.17834071,FoxO signaling pathway,5.62E-28,27.24994485
hsa00520,0.125570969,"19% O2, CyA- vs 1% O2, CyA+",0.901110754,Amino sugar and nucleotide sugar metabolism,1,0
hsa00860,0.508150628,"19% O2, CyA- vs 1% O2, CyA+",0.294007533,Porphyrin metabolism,1,0
hsa04922,1.20E-90,"19% O2, CyA- vs 1% O2, CyA+",89.92177557,Glucagon signaling pathway,1.04E-87,86.98275579
hsa04926,0.273247792,"19% O2, CyA- vs 1% O2, CyA+",0.563443338,Relaxin signaling pathway,1,0
hsa04370,3.10E-08,"19% O2, CyA- vs 1% O2, CyA+",7.50925718,VEGF signaling pathway,2.34E-05,4.631310228
hsa05213,5.26E-118,"19% O2, CyA- vs 1% O2, CyA+",117.2786391,Endometrial cancer,4.60E-115,114.3376249
hsa04520,3.21E-23,"19% O2, CyA- vs 1% O2, CyA+",22.49379119,Adherens junction,2.67E-20,19.57314619
hsa05110,0.003744733,"19% O2, CyA- vs 1% O2, CyA+",2.42657914,Vibrio cholerae infection,1,0
hsa05220,0.291186261,"19% O2, CyA- vs 1% O2, CyA+",0.535829119,Chronic myeloid leukemia,1,0
hsa05235,0.000462657,"19% O2, CyA- vs 1% O2, CyA+",3.334740458,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.301652645,0.520492862
hsa05207,5.75E-10,"19% O2, CyA- vs 1% O2, CyA+",9.240113216,Chemical carcinogenesis - receptor activation,4.43E-07,6.353622491
hsa05418,0.006488595,"19% O2, CyA- vs 1% O2, CyA+",2.187849305,Fluid shear stress and atherosclerosis,1,0
hsa00920,0.484231397,"19% O2, CyA- vs 1% O2, CyA+",0.314947055,Sulfur metabolism,1,0
hsa04931,0.002276289,"19% O2, CyA- vs 1% O2, CyA+",2.642772615,Insulin resistance,1,0
hsa00500,0.291743516,"19% O2, CyA- vs 1% O2, CyA+",0.534998788,Starch and sucrose metabolism,1,0
hsa05216,0.215393185,"19% O2, CyA- vs 1% O2, CyA+",0.666768042,Thyroid cancer,1,0
hsa00740,0.422109269,"19% O2, CyA- vs 1% O2, CyA+",0.374575112,Riboflavin metabolism,1,0
hsa00062,0.508050177,"19% O2, CyA- vs 1% O2, CyA+",0.294093393,Fatty acid elongation,1,0
hsa04390,0.467259871,"19% O2, CyA- vs 1% O2, CyA+",0.330441515,Hippo signaling pathway,1,0
hsa04064,0.265668355,"19% O2, CyA- vs 1% O2, CyA+",0.575660173,NF-kappa B signaling pathway,1,0
hsa04932,1.13E-15,"19% O2, CyA- vs 1% O2, CyA+",14.94694043,Non-alcoholic fatty liver disease,9.06E-13,12.04276606
hsa05222,0.439627648,"19% O2, CyA- vs 1% O2, CyA+",0.356915003,Small cell lung cancer,1,0
hsa05320,0.545915112,"19% O2, CyA- vs 1% O2, CyA+",0.262874884,Autoimmune thyroid disease,1,0
hsa04115,0.065637009,"19% O2, CyA- vs 1% O2, CyA+",1.18285122,p53 signaling pathway,1,0
hsa04710,8.81E-184,"19% O2, CyA- vs 1% O2, CyA+",183.05519,Circadian rhythm,7.73E-181,180.1116955
hsa05206,0.033388613,"19% O2, CyA- vs 1% O2, CyA+",1.476401628,MicroRNAs in cancer,1,0
hsa05032,0.494996862,"19% O2, CyA- vs 1% O2, CyA+",0.305397555,Morphine addiction,1,0
hsa00620,0.459049401,"19% O2, CyA- vs 1% O2, CyA+",0.338140575,Pyruvate metabolism,1,0
hsa05132,3.43E-14,"19% O2, CyA- vs 1% O2, CyA+",13.46526784,Salmonella infection,2.72E-11,10.56599465
hsa04658,0.297079058,"19% O2, CyA- vs 1% O2, CyA+",0.527127963,Th1 and Th2 cell differentiation,1,0
hsa05014,2.86E-81,"19% O2, CyA- vs 1% O2, CyA+",80.54372499,Amyotrophic lateral sclerosis,2.48E-78,77.60520526
hsa04933,0.45365113,"19% O2, CyA- vs 1% O2, CyA+",0.343278003,AGE-RAGE signaling pathway in diabetic complications,1,0
hsa00531,0.467112566,"19% O2, CyA- vs 1% O2, CyA+",0.33057845,Glycosaminoglycan degradation,1,0
hsa04714,6.37E-05,"19% O2, CyA- vs 1% O2, CyA+",4.195814751,Thermogenesis,0.043256863,1.363944976
hsa00592,0.306045762,"19% O2, CyA- vs 1% O2, CyA+",0.51421363,alpha-Linolenic acid metabolism,1,0
hsa05170,0.235308692,"19% O2, CyA- vs 1% O2, CyA+",0.62836203,Human immunodeficiency virus 1 infection,1,0
hsa05160,0.000218939,"19% O2, CyA- vs 1% O2, CyA+",3.659676041,Hepatitis C,0.145156834,0.838162512
hsa04392,0.318503825,"19% O2, CyA- vs 1% O2, CyA+",0.496885348,Hippo signaling pathway - multiple species,1,0
hsa04666,9.44E-17,"19% O2, CyA- vs 1% O2, CyA+",16.02518319,Fc gamma R-mediated phagocytosis,7.64E-14,13.11669817
hsa04920,0.439606329,"19% O2, CyA- vs 1% O2, CyA+",0.356936064,Adipocytokine signaling pathway,1,0
hsa04940,0.540706124,"19% O2, CyA- vs 1% O2, CyA+",0.267038711,Type I diabetes mellitus,1,0
hsa04672,0.264465113,"19% O2, CyA- vs 1% O2, CyA+",0.577631611,Intestinal immune network for IgA production,1,0
hsa00780,0.555590922,"19% O2, CyA- vs 1% O2, CyA+",0.255244859,Biotin metabolism,1,0
hsa00590,0.469735675,"19% O2, CyA- vs 1% O2, CyA+",0.328146455,Arachidonic acid metabolism,1,0
hsa05161,0.020183883,"19% O2, CyA- vs 1% O2, CyA+",1.694995282,Hepatitis B,1,0
hsa04540,0.15667917,"19% O2, CyA- vs 1% O2, CyA+",0.804988737,Gap junction,1,0
hsa04913,1.89E-07,"19% O2, CyA- vs 1% O2, CyA+",6.724292932,Ovarian steroidogenesis,0.000140372,3.852719996
hsa05212,0.364569265,"19% O2, CyA- vs 1% O2, CyA+",0.438219948,Pancreatic cancer,1,0
hsa05211,0.020627596,"19% O2, CyA- vs 1% O2, CyA+",1.68555139,Renal cell carcinoma,1,0
hsa04371,0.000830941,"19% O2, CyA- vs 1% O2, CyA+",3.080429574,Apelin signaling pathway,0.535957238,0.27086986
hsa05164,0.407368208,"19% O2, CyA- vs 1% O2, CyA+",0.390012867,Influenza A,1,0
hsa04146,0.00125983,"19% O2, CyA- vs 1% O2, CyA+",2.899688028,Peroxisome,0.799992098,0.096914303
hsa04122,0.196988343,"19% O2, CyA- vs 1% O2, CyA+",0.705559474,Sulfur relay system,1,0
hsa05167,0.15919147,"19% O2, CyA- vs 1% O2, CyA+",0.798080206,Kaposi sarcoma-associated herpesvirus infection,1,0
hsa00562,0.209477167,"19% O2, CyA- vs 1% O2, CyA+",0.678863308,Inositol phosphate metabolism,1,0
hsa04935,3.13E-07,"19% O2, CyA- vs 1% O2, CyA+",6.504038655,"Growth hormone synthesis, secretion and action",0.000230589,3.637160841
hsa00240,0.37105524,"19% O2, CyA- vs 1% O2, CyA+",0.430561431,Pyrimidine metabolism,1,0
hsa05200,4.36E-10,"19% O2, CyA- vs 1% O2, CyA+",9.36083358,Pathways in cancer,3.36E-07,6.473779202
hsa00480,0.491429243,"19% O2, CyA- vs 1% O2, CyA+",0.308539004,Glutathione metabolism,1,0
hsa04150,1.06E-05,"19% O2, CyA- vs 1% O2, CyA+",4.97482651,mTOR signaling pathway,0.007438932,2.128489397
hsa05034,0.017616073,"19% O2, CyA- vs 1% O2, CyA+",1.754090887,Alcoholism,1,0
hsa04750,0.492282565,"19% O2, CyA- vs 1% O2, CyA+",0.307785545,Inflammatory mediator regulation of TRP channels,1,0
hsa04137,0.111962422,"19% O2, CyA- vs 1% O2, CyA+",0.950927715,Mitophagy - animal,1,0
hsa05203,4.49E-06,"19% O2, CyA- vs 1% O2, CyA+",5.347363655,Viral carcinogenesis,0.003204246,2.494274125
hsa03320,0.502190701,"19% O2, CyA- vs 1% O2, CyA+",0.299131333,PPAR signaling pathway,1,0
hsa00564,0.499412415,"19% O2, CyA- vs 1% O2, CyA+",0.301540666,Glycerophospholipid metabolism,1,0
hsa04961,0.481888554,"19% O2, CyA- vs 1% O2, CyA+",0.317053389,Endocrine and other factor-regulated calcium reabsorption,1,0
hsa00220,0.514415064,"19% O2, CyA- vs 1% O2, CyA+",0.288686322,Arginine biosynthesis,1,0
hsa05168,6.52E-11,"19% O2, CyA- vs 1% O2, CyA+",10.18585831,Herpes simplex virus 1 infection,5.08E-08,7.293763706
hsa04061,2.52E-05,"19% O2, CyA- vs 1% O2, CyA+",4.598777399,Viral protein interaction with cytokine and cytokine receptor,0.017380877,1.759928308
hsa05412,0.314048626,"19% O2, CyA- vs 1% O2, CyA+",0.503003102,Arrhythmogenic right ventricular cardiomyopathy,1,0
hsa04924,0.339678071,"19% O2, CyA- vs 1% O2, CyA+",0.468932489,Renin secretion,1,0
hsa05143,0.443448079,"19% O2, CyA- vs 1% O2, CyA+",0.353157222,African trypanosomiasis,1,0
hsa04960,0.342307694,"19% O2, CyA- vs 1% O2, CyA+",0.465583339,Aldosterone-regulated sodium reabsorption,1,0
hsa05162,0.363967086,"19% O2, CyA- vs 1% O2, CyA+",0.438937888,Measles,1,0
hsa00730,0.434946917,"19% O2, CyA- vs 1% O2, CyA+",0.361563743,Thiamine metabolism,1,0
hsa05030,0.04720857,"19% O2, CyA- vs 1% O2, CyA+",1.325979155,Cocaine addiction,1,0
hsa00750,0.451213155,"19% O2, CyA- vs 1% O2, CyA+",0.345618247,Vitamin B6 metabolism,1,0
hsa04623,0.442229164,"19% O2, CyA- vs 1% O2, CyA+",0.35435262,Cytosolic DNA-sensing pathway,1,0
hsa00650,0.237465778,"19% O2, CyA- vs 1% O2, CyA+",0.624398969,Butanoate metabolism,1,0
hsa05010,0.367185477,"19% O2, CyA- vs 1% O2, CyA+",0.435114504,Alzheimer disease,1,0
hsa05031,5.82E-07,"19% O2, CyA- vs 1% O2, CyA+",6.23511924,Amphetamine addiction,0.000424819,3.37179638
hsa00071,0.176450398,"19% O2, CyA- vs 1% O2, CyA+",0.753377357,Fatty acid degradation,1,0
hsa00561,0.373503104,"19% O2, CyA- vs 1% O2, CyA+",0.427705785,Glycerolipid metabolism,1,0
hsa04614,0.45753769,"19% O2, CyA- vs 1% O2, CyA+",0.339573125,Renin-angiotensin system,1,0
hsa04971,0.294309766,"19% O2, CyA- vs 1% O2, CyA+",0.531195327,Gastric acid secretion,1,0
hsa04215,7.73E-11,"19% O2, CyA- vs 1% O2, CyA+",10.111672,Apoptosis - multiple species,6.02E-08,7.220134546
hsa04080,0.322067354,"19% O2, CyA- vs 1% O2, CyA+",0.492053295,Neuroactive ligand-receptor interaction,1,0
hsa05231,0.381463193,"19% O2, CyA- vs 1% O2, CyA+",0.41854736,Choline metabolism in cancer,1,0
hsa05166,3.66E-15,"19% O2, CyA- vs 1% O2, CyA+",14.43691825,Human T-cell leukemia virus 1 infection,2.91E-12,11.53545993
hsa00790,0.449321183,"19% O2, CyA- vs 1% O2, CyA+",0.347443107,Folate biosynthesis,1,0
hsa00983,0.327865211,"19% O2, CyA- vs 1% O2, CyA+",0.484304663,Drug metabolism - other enzymes,1,0
hsa04721,0.012170436,"19% O2, CyA- vs 1% O2, CyA+",1.914693849,Synaptic vesicle cycle,1,0
hsa04218,0.002536235,"19% O2, CyA- vs 1% O2, CyA+",2.595810509,Cellular senescence,1,0
hsa04530,7.53E-17,"19% O2, CyA- vs 1% O2, CyA+",16.12320171,Tight junction,6.11E-14,13.21418086
hsa04340,0.388008249,"19% O2, CyA- vs 1% O2, CyA+",0.411159041,Hedgehog signaling pathway,1,0
hsa04725,9.92E-06,"19% O2, CyA- vs 1% O2, CyA+",5.003680832,Cholinergic synapse,0.00697067,2.156725507
hsa04740,0.51005686,"19% O2, CyA- vs 1% O2, CyA+",0.292381407,Olfactory transduction,1,0
hsa04152,5.33E-06,"19% O2, CyA- vs 1% O2, CyA+",5.273236797,AMPK signaling pathway,0.003768622,2.423817384
hsa03460,1.24E-37,"19% O2, CyA- vs 1% O2, CyA+",36.90832813,Fanconi anemia pathway,1.05E-34,33.97687026
hsa05214,0.005811768,"19% O2, CyA- vs 1% O2, CyA+",2.235691745,Glioma,1,0
hsa00440,0.532607497,"19% O2, CyA- vs 1% O2, CyA+",0.273592725,Phosphonate and phosphinate metabolism,1,0
hsa04020,0.351975546,"19% O2, CyA- vs 1% O2, CyA+",0.453487508,Calcium signaling pathway,1,0
hsa04514,5.13E-33,"19% O2, CyA- vs 1% O2, CyA+",32.28971173,Cell adhesion molecules,4.37E-30,29.35978217
hsa04613,7.81E-45,"19% O2, CyA- vs 1% O2, CyA+",44.10740355,Neutrophil extracellular trap formation,6.72E-42,41.1724004
hsa00250,0.452164685,"19% O2, CyA- vs 1% O2, CyA+",0.34470336,"Alanine, aspartate and glutamate metabolism",1,0
hsa04217,0.045615932,"19% O2, CyA- vs 1% O2, CyA+",1.340883448,Necroptosis,1,0
hsa04934,0.001930681,"19% O2, CyA- vs 1% O2, CyA+",2.714289402,Cushing syndrome,1,0
hsa05140,0.001922323,"19% O2, CyA- vs 1% O2, CyA+",2.716173696,Leishmaniasis,1,0
hsa04919,2.59E-299,"19% O2, CyA- vs 1% O2, CyA+",298.5867588,Thyroid hormone signaling pathway,2.28E-296,295.6417829
hsa04550,0.037263989,"19% O2, CyA- vs 1% O2, CyA+",1.428710654,Signaling pathways regulating pluripotency of stem cells,1,0
hsa00061,1.96E-05,"19% O2, CyA- vs 1% O2, CyA+",4.708427548,Fatty acid biosynthesis,0.013600575,1.866442743
hsa00532,0.469459979,"19% O2, CyA- vs 1% O2, CyA+",0.328401425,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0
hsa04742,0.408401161,"19% O2, CyA- vs 1% O2, CyA+",0.388913032,Taste transduction,1,0
hsa04261,0.093522901,"19% O2, CyA- vs 1% O2, CyA+",1.029082032,Adrenergic signaling in cardiomyocytes,1,0
hsa04910,0.015947332,"19% O2, CyA- vs 1% O2, CyA+",1.79731196,Insulin signaling pathway,1,0
hsa04015,0.000111477,"19% O2, CyA- vs 1% O2, CyA+",3.952816312,Rap1 signaling pathway,0.074912271,1.125447039
hsa05208,0.04392884,"19% O2, CyA- vs 1% O2, CyA+",1.35725026,Chemical carcinogenesis - reactive oxygen species,1,0
hsa04914,1.04E-76,"19% O2, CyA- vs 1% O2, CyA+",75.9812442,Progesterone-mediated oocyte maturation,9.05E-74,73.0432251
hsa04130,0.327207644,"19% O2, CyA- vs 1% O2, CyA+",0.48517656,SNARE interactions in vesicular transport,1,0
hsa00640,8.09E-35,"19% O2, CyA- vs 1% O2, CyA+",34.0921443,Propanoate metabolism,6.90E-32,31.16119527
hsa00450,0.411435197,"19% O2, CyA- vs 1% O2, CyA+",0.385698559,Selenocompound metabolism,1,0
hsa04621,3.57E-25,"19% O2, CyA- vs 1% O2, CyA+",24.44755083,NOD-like receptor signaling pathway,2.98E-22,21.52638478
hsa05130,0.053380277,"19% O2, CyA- vs 1% O2, CyA+",1.272619176,Pathogenic Escherichia coli infection,1,0
hsa04670,0.293784919,"19% O2, CyA- vs 1% O2, CyA+",0.531970501,Leukocyte transendothelial migration,1,0
hsa04928,2.73E-111,"19% O2, CyA- vs 1% O2, CyA+",110.5643386,"Parathyroid hormone synthesis, secretion and action",2.38E-108,107.6238221
hsa00130,0.524199618,"19% O2, CyA- vs 1% O2, CyA+",0.2805033,Ubiquinone and other terpenoid-quinone biosynthesis,1,0
hsa05100,1.93E-07,"19% O2, CyA- vs 1% O2, CyA+",6.714096522,Bacterial invasion of epithelial cells,0.000143513,3.843107708
hsa05414,0.186307625,"19% O2, CyA- vs 1% O2, CyA+",0.72976937,Dilated cardiomyopathy,1,0
hsa05321,0.488711343,"19% O2, CyA- vs 1% O2, CyA+",0.310947581,Inflammatory bowel disease,1,0
hsa00051,4.88E-06,"19% O2, CyA- vs 1% O2, CyA+",5.31139875,Fructose and mannose metabolism,0.00347113,2.45952915
hsa05230,0.073470446,"19% O2, CyA- vs 1% O2, CyA+",1.133887326,Central carbon metabolism in cancer,1,0
hsa04727,0.024748907,"19% O2, CyA- vs 1% O2, CyA+",1.606443979,GABAergic synapse,1,0
hsa04630,0.236743279,"19% O2, CyA- vs 1% O2, CyA+",0.625722341,JAK-STAT signaling pathway,1,0
hsa00603,0.508700153,"19% O2, CyA- vs 1% O2, CyA+",0.293538132,Glycosphingolipid biosynthesis - globo and isoglobo series,1,0
hsa00340,0.482809984,"19% O2, CyA- vs 1% O2, CyA+",0.316223758,Histidine metabolism,1,0
hsa04610,0.507154059,"19% O2, CyA- vs 1% O2, CyA+",0.294860094,Complement and coagulation cascades,1,0
hsa05205,0.070177842,"19% O2, CyA- vs 1% O2, CyA+",1.153799993,Proteoglycans in cancer,1,0
hsa04140,8.41E-29,"19% O2, CyA- vs 1% O2, CyA+",28.07495938,Autophagy - animal,7.10E-26,25.14861693
hsa00010,0.412923684,"19% O2, CyA- vs 1% O2, CyA+",0.384130207,Glycolysis / Gluconeogenesis,1,0
hsa04144,1.08E-19,"19% O2, CyA- vs 1% O2, CyA+",18.96812844,Endocytosis,8.86E-17,16.05272861
hsa01521,0.000249863,"19% O2, CyA- vs 1% O2, CyA+",3.602297515,EGFR tyrosine kinase inhibitor resistance,0.16540951,0.781439525
hsa05415,0.267876474,"19% O2, CyA- vs 1% O2, CyA+",0.572065425,Diabetic cardiomyopathy,1,0
hsa05133,0.040578555,"19% O2, CyA- vs 1% O2, CyA+",1.391703417,Pertussis,1,0
hsa04620,1.96E-05,"19% O2, CyA- vs 1% O2, CyA+",4.708394713,Toll-like receptor signaling pathway,0.013600575,1.866442743
hsa00980,0.472184194,"19% O2, CyA- vs 1% O2, CyA+",0.325888555,Metabolism of xenobiotics by cytochrome P450,1,0
hsa01524,9.64E-12,"19% O2, CyA- vs 1% O2, CyA+",11.01600757,Platinum drug resistance,7.56E-09,8.121691503
hsa00630,0.427037398,"19% O2, CyA- vs 1% O2, CyA+",0.369534089,Glyoxylate and dicarboxylate metabolism,1,0
hsa05022,0.000198317,"19% O2, CyA- vs 1% O2, CyA+",3.702639097,Pathways of neurodegeneration - multiple diseases,0.131881096,0.879817452
hsa05165,0.189997765,"19% O2, CyA- vs 1% O2, CyA+",0.721251508,Human papillomavirus infection,1,0
hsa04330,0.48013985,"19% O2, CyA- vs 1% O2, CyA+",0.318632247,Notch signaling pathway,1,0
hsa04927,0.003480449,"19% O2, CyA- vs 1% O2, CyA+",2.458364746,Cortisol synthesis and secretion,1,0
hsa01523,0.181230636,"19% O2, CyA- vs 1% O2, CyA+",0.741768387,Antifolate resistance,1,0
hsa05323,0.422819342,"19% O2, CyA- vs 1% O2, CyA+",0.373845154,Rheumatoid arthritis,1,0
hsa00563,0.518838752,"19% O2, CyA- vs 1% O2, CyA+",0.284967594,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1,0
hsa04917,0.071057268,"19% O2, CyA- vs 1% O2, CyA+",1.148391495,Prolactin signaling pathway,1,0
hsa05135,2.15E-10,"19% O2, CyA- vs 1% O2, CyA+",9.667281232,Yersinia infection,1.67E-07,6.777979529
hsa04612,0.457563245,"19% O2, CyA- vs 1% O2, CyA+",0.339548869,Antigen processing and presentation,1,0
hsa00330,0.527675909,"19% O2, CyA- vs 1% O2, CyA+",0.277632733,Arginine and proline metabolism,1,0
hsa05016,3.48E-05,"19% O2, CyA- vs 1% O2, CyA+",4.458894368,Huntington disease,0.023812018,1.623203796
hsa04141,3.86E-11,"19% O2, CyA- vs 1% O2, CyA+",10.41353253,Protein processing in endoplasmic reticulum,3.01E-08,7.520881498
hsa04979,0.064666883,"19% O2, CyA- vs 1% O2, CyA+",1.189318074,Cholesterol metabolism,1,0
hsa00670,0.438826789,"19% O2, CyA- vs 1% O2, CyA+",0.357706868,One carbon pool by folate,1,0
hsa00260,0.51897905,"19% O2, CyA- vs 1% O2, CyA+",0.284850173,"Glycine, serine and threonine metabolism",1,0
hsa04730,1.05E-22,"19% O2, CyA- vs 1% O2, CyA+",21.98013042,Long-term depression,8.69E-20,19.06105233
hsa04650,3.02E-41,"19% O2, CyA- vs 1% O2, CyA+",40.52051027,Natural killer cell mediated cytotoxicity,2.59E-38,37.58702298
hsa04720,3.84E-18,"19% O2, CyA- vs 1% O2, CyA+",17.41526392,Long-term potentiation,3.12E-15,14.50517338
hsa00360,0.529732424,"19% O2, CyA- vs 1% O2, CyA+",0.275943444,Phenylalanine metabolism,1,0
hsa05020,5.26E-06,"19% O2, CyA- vs 1% O2, CyA+",5.279289462,Prion disease,0.003721721,2.429256204
hsa00760,0.522066857,"19% O2, CyA- vs 1% O2, CyA+",0.282273877,Nicotinate and nicotinamide metabolism,1,0
hsa05210,6.33E-13,"19% O2, CyA- vs 1% O2, CyA+",12.19832816,Colorectal cancer,4.99E-10,9.301801946
hsa03018,0.274567539,"19% O2, CyA- vs 1% O2, CyA+",0.56135081,RNA degradation,1,0
hsa00410,0.5176033,"19% O2, CyA- vs 1% O2, CyA+",0.286002964,beta-Alanine metabolism,1,0
hsa00565,0.478358242,"19% O2, CyA- vs 1% O2, CyA+",0.320246739,Ether lipid metabolism,1,0
hsa04350,0.417305303,"19% O2, CyA- vs 1% O2, CyA+",0.379546096,TGF-beta signaling pathway,1,0
hsa05150,0.428416448,"19% O2, CyA- vs 1% O2, CyA+",0.368133864,Staphylococcus aureus infection,1,0
hsa00120,0.561893799,"19% O2, CyA- vs 1% O2, CyA+",0.250345761,Primary bile acid biosynthesis,1,0
hsa04810,1.88E-28,"19% O2, CyA- vs 1% O2, CyA+",27.72507007,Regulation of actin cytoskeleton,1.59E-25,24.7992425
hsa05144,0.509198184,"19% O2, CyA- vs 1% O2, CyA+",0.293113154,Malaria,1,0
hsa04072,2.45E-31,"19% O2, CyA- vs 1% O2, CyA+",30.61031736,Phospholipase D signaling pathway,2.08E-28,27.68089843
hsa00910,0.000369888,"19% O2, CyA- vs 1% O2, CyA+",3.431929657,Nitrogen metabolism,0.242276696,0.615688357
hsa00513,0.485953238,"19% O2, CyA- vs 1% O2, CyA+",0.31340552,Various types of N-glycan biosynthesis,1,0
hsa05134,0.361349059,"19% O2, CyA- vs 1% O2, CyA+",0.442073072,Legionellosis,1,0
hsa04970,0.24342955,"19% O2, CyA- vs 1% O2, CyA+",0.613626703,Salivary secretion,1,0
hsa05171,0.473770592,"19% O2, CyA- vs 1% O2, CyA+",0.324431901,Coronavirus disease - COVID-19,1,0
hsa05017,4.21E-13,"19% O2, CyA- vs 1% O2, CyA+",12.37602312,Spinocerebellar ataxia,3.32E-10,9.478396024
hsa04976,0.467932172,"19% O2, CyA- vs 1% O2, CyA+",0.329817095,Bile secretion,1,0
hsa04060,0.1132056,"19% O2, CyA- vs 1% O2, CyA+",0.946132088,Cytokine-cytokine receptor interaction,1,0
hsa04925,2.48E-06,"19% O2, CyA- vs 1% O2, CyA+",5.6050386,Aldosterone synthesis and secretion,0.001782731,2.748914155
hsa00280,0.306055402,"19% O2, CyA- vs 1% O2, CyA+",0.514199951,"Valine, leucine and isoleucine degradation",1,0
hsa00380,0.471854342,"19% O2, CyA- vs 1% O2, CyA+",0.326192044,Tryptophan metabolism,1,0
hsa04662,0.003035052,"19% O2, CyA- vs 1% O2, CyA+",2.517833798,B cell receptor signaling pathway,1,0
hsa00970,0.252268582,"19% O2, CyA- vs 1% O2, CyA+",0.598136835,Aminoacyl-tRNA biosynthesis,1,0
hsa04936,0.276130798,"19% O2, CyA- vs 1% O2, CyA+",0.558885152,Alcoholic liver disease,1,0
hsa04923,0.372771995,"19% O2, CyA- vs 1% O2, CyA+",0.428556722,Regulation of lipolysis in adipocytes,1,0
hsa05215,1.76E-05,"19% O2, CyA- vs 1% O2, CyA+",4.755014788,Prostate cancer,0.012269889,1.911159366
hsa05224,0.012286856,"19% O2, CyA- vs 1% O2, CyA+",1.910559219,Breast cancer,1,0
hsa04014,0.094445938,"19% O2, CyA- vs 1% O2, CyA+",1.024816714,Ras signaling pathway,1,0
hsa04151,0.337923431,"19% O2, CyA- vs 1% O2, CyA+",0.471181695,PI3K-Akt signaling pathway,1,0
hsa05417,0.438033434,"19% O2, CyA- vs 1% O2, CyA+",0.35849274,Lipid and atherosclerosis,1,0
hsa04210,9.85E-16,"19% O2, CyA- vs 1% O2, CyA+",15.00635342,Apoptosis,7.91E-13,12.10163788
hsa04713,4.80E-41,"19% O2, CyA- vs 1% O2, CyA+",40.31912639,Circadian entrainment,4.11E-38,37.38614557
hsa05120,1.30E-07,"19% O2, CyA- vs 1% O2, CyA+",6.887170425,Epithelial cell signaling in Helicobacter pylori infection,9.67E-05,4.014431598
hsa00350,0.513512349,"19% O2, CyA- vs 1% O2, CyA+",0.289449108,Tyrosine metabolism,1,0
hsa05322,0.524850609,"19% O2, CyA- vs 1% O2, CyA+",0.279964295,Systemic lupus erythematosus,1,0
hsa05163,0.204669886,"19% O2, CyA- vs 1% O2, CyA+",0.688946051,Human cytomegalovirus infection,1,0
hsa00030,4.01E-20,"19% O2, CyA- vs 1% O2, CyA+",19.39661145,Pentose phosphate pathway,3.31E-17,16.4796314
hsa00230,0.469787116,"19% O2, CyA- vs 1% O2, CyA+",0.328098898,Purine metabolism,1,0
hsa04211,8.79E-28,"19% O2, CyA- vs 1% O2, CyA+",27.05606408,Longevity regulating pathway,7.38E-25,24.1317848
hsa04611,0.000154731,"19% O2, CyA- vs 1% O2, CyA+",3.81042361,Platelet activation,0.103360084,0.985647147
hsa04012,0.000135206,"19% O2, CyA- vs 1% O2, CyA+",3.869004219,ErbB signaling pathway,0.090587982,1.042929416
hsa04728,0.218855075,"19% O2, CyA- vs 1% O2, CyA+",0.659843379,Dopaminergic synapse,1,0
hsa05219,0.137432815,"19% O2, CyA- vs 1% O2, CyA+",0.861909559,Bladder cancer,1,0
hsa00600,0.40334132,"19% O2, CyA- vs 1% O2, CyA+",0.394327285,Sphingolipid metabolism,1,0
hsa04972,0.244081116,"19% O2, CyA- vs 1% O2, CyA+",0.612465821,Pancreatic secretion,1,0
hsa04360,1.33E-213,"19% O2, CyA- vs 1% O2, CyA+",212.8761469,Axon guidance,1.17E-210,209.9321581
hsa04722,0.006044808,"19% O2, CyA- vs 1% O2, CyA+",2.218617496,Neurotrophin signaling pathway,1,0
hsa00512,0.518819012,"19% O2, CyA- vs 1% O2, CyA+",0.284984118,Mucin type O-glycan biosynthesis,1,0
hsa04723,0.450186829,"19% O2, CyA- vs 1% O2, CyA+",0.346607215,Retrograde endocannabinoid signaling,1,0
hsa00601,0.526319991,"19% O2, CyA- vs 1% O2, CyA+",0.278750134,Glycosphingolipid biosynthesis - lacto and neolacto series,1,0
hsa05204,0.33205174,"19% O2, CyA- vs 1% O2, CyA+",0.47879424,Chemical carcinogenesis - DNA adducts,1,0
hsa04071,3.41E-16,"19% O2, CyA- vs 1% O2, CyA+",15.46753966,Sphingolipid signaling pathway,2.74E-13,12.56174378
hsa04213,2.99E-19,"19% O2, CyA- vs 1% O2, CyA+",18.5240754,Longevity regulating pathway - multiple species,2.45E-16,15.61026155
hsa04270,6.51E-05,"19% O2, CyA- vs 1% O2, CyA+",4.186328343,Vascular smooth muscle contraction,0.044147016,1.35509865
hsa04918,0.057161352,"19% O2, CyA- vs 1% O2, CyA+",1.242897509,Thyroid hormone synthesis,1,0
hsa04657,0.066267241,"19% O2, CyA- vs 1% O2, CyA+",1.17870111,IL-17 signaling pathway,1,0
hsa04622,0.287252496,"19% O2, CyA- vs 1% O2, CyA+",0.541736189,RIG-I-like receptor signaling pathway,1,0
hsa00052,0.376011961,"19% O2, CyA- vs 1% O2, CyA+",0.42479834,Galactose metabolism,1,0
hsa00515,0.532257288,"19% O2, CyA- vs 1% O2, CyA+",0.273878383,Mannose type O-glycan biosynthesis,1,0
hsa04659,0.321752839,"19% O2, CyA- vs 1% O2, CyA+",0.492477612,Th17 cell differentiation,1,0
hsa00270,0.49038023,"19% O2, CyA- vs 1% O2, CyA+",0.309467047,Cysteine and methionine metabolism,1,0
hsa04915,0.286331754,"19% O2, CyA- vs 1% O2, CyA+",0.543130486,Estrogen signaling pathway,1,0
hsa04216,0.002418489,"19% O2, CyA- vs 1% O2, CyA+",2.616455848,Ferroptosis,1,0
hsa04512,0.458784354,"19% O2, CyA- vs 1% O2, CyA+",0.338391401,ECM-receptor interaction,1,0
hsa04510,8.64E-156,"19% O2, CyA- vs 1% O2, CyA+",155.0636663,Focal adhesion,7.56E-153,152.1216582
hsa04668,3.22E-18,"19% O2, CyA- vs 1% O2, CyA+",17.49241998,TNF signaling pathway,2.62E-15,14.58179557
hsa05226,1.35E-05,"19% O2, CyA- vs 1% O2, CyA+",4.868840228,Gastric cancer,0.00946799,2.023742188
hsa00770,0.534092348,"19% O2, CyA- vs 1% O2, CyA+",0.272383644,Pantothenate and CoA biosynthesis,1,0
hsa05131,0.000103337,"19% O2, CyA- vs 1% O2, CyA+",3.985743256,Shigellosis,0.069649282,1.157083359
hsa01522,0.20285557,"19% O2, CyA- vs 1% O2, CyA+",0.692813063,Endocrine resistance,1,0
hsa04062,0.406377813,"19% O2, CyA- vs 1% O2, CyA+",0.391070012,Chemokine signaling pathway,1,0
hsa04911,0.099052859,"19% O2, CyA- vs 1% O2, CyA+",1.004132984,Insulin secretion,1,0
hsa00040,0.510000556,"19% O2, CyA- vs 1% O2, CyA+",0.29242935,Pentose and glucuronate interconversions,1,0
hsa04930,0.325210031,"19% O2, CyA- vs 1% O2, CyA+",0.487836067,Type II diabetes mellitus,1,0
hsa05202,6.56E-09,"19% O2, CyA- vs 1% O2, CyA+",8.183398821,Transcriptional misregulation in cancer,5.00E-06,5.300874283
hsa05145,0.312021409,"19% O2, CyA- vs 1% O2, CyA+",0.505815607,Toxoplasmosis,1,0
hsa04380,4.43E-07,"19% O2, CyA- vs 1% O2, CyA+",6.35379101,Osteoclast differentiation,0.000324573,3.488687035
hsa04010,0.019729393,"19% O2, CyA- vs 1% O2, CyA+",1.704886284,MAPK signaling pathway,1,0
hsa05142,0.445799903,"19% O2, CyA- vs 1% O2, CyA+",0.350860031,Chagas disease,1,0
hsa00020,0.388645003,"19% O2, CyA- vs 1% O2, CyA+",0.410446912,Citrate cycle (TCA cycle),1,0
hsa04744,0.526931166,"19% O2, CyA- vs 1% O2, CyA+",0.278246114,Phototransduction,1,0
hsa04921,1.71E-05,"19% O2, CyA- vs 1% O2, CyA+",4.765978732,Oxytocin signaling pathway,0.011981148,1.921501557
